|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases response to substance |
ISO |
NFE2L2 protein results in decreased susceptibility to Hydroquinones |
CTD |
PMID:20932822 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
1,4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein; [1,4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [1,4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA |
CTD |
PMID:27837168 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[1,4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA |
CTD |
PMID:27837168 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[1,4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA |
CTD |
PMID:27837168 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Gpr35 |
G protein-coupled receptor 35 |
multiple interactions |
ISO |
1,4-dihydroxy-2-naphthoic acid binds to and results in increased activity of GPR35 protein |
CTD |
PMID:20826425 |
|
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
2,5-di-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] |
CTD |
PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
2,5-di-tert-butylhydroquinone results in increased expression of GSTP1 protein |
CTD |
PMID:12680784 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases response to substance |
ISO |
NFE2L2 gene mutant form results in increased susceptibility to 2,5-di-tert-butylhydroquinone |
CTD |
PMID:12842875 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
2,5-di-tert-butylhydroquinone binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
2,5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with methyl 2,5-dihydroxycinnamate] |
CTD |
PMID:8471626 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of ABCC1 mRNA; 2-tert-butylhydroquinone results in increased expression of ABCC1 protein |
CTD |
PMID:11836020 PMID:16014739 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO EXP |
2-tert-butylhydroquinone results in increased expression of ABCC2 mRNA; 2-tert-butylhydroquinone results in increased expression of ABCC2 protein |
CTD |
PMID:11264000 PMID:11836020 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of ABCG2 mRNA; 2-tert-butylhydroquinone results in increased expression of ABCG2 protein AHR protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of ABCG2 protein] |
CTD |
PMID:17077187 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of ADH7 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO EXP |
AHR protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of ABCG2 protein]; AHR protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of UGT1A6 mRNA] 2-tert-butylhydroquinone results in increased activity of and results in increased localization of AHR protein |
CTD |
PMID:12948865 PMID:15608132 PMID:17077187 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of AKR1B10 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of AKR1C1 mRNA |
CTD |
PMID:9973208 PMID:30806763 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:23112101 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tert-butylhydroquinone inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:18324785 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [thallium nitrate results in decreased expression of ATP5F1A protein] |
CTD |
PMID:31726083 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of B4GALT1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
affects localization multiple interactions |
ISO |
2-tert-butylhydroquinone affects the localization of BACH1 protein 2-tert-butylhydroquinone promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of BACH1 protein]; [ferric chloride results in increased oxidation of 2-tert-butylhydroquinone] promotes the reaction [2-tert-butylhydroquinone analog binds to BACH1 protein] |
CTD |
PMID:28645578 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
2-tert-butylhydroquinone results in decreased expression of BAX protein [2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in decreased expression of BAX protein 2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in increased expression of BAX protein] 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in increased expression of BAX mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of BAX protein]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in increased expression of BAX protein] |
CTD |
PMID:22275372 PMID:26878773 PMID:28583816 PMID:32565124 PMID:37075934 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to BCL2 promoter]; [2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in increased expression of BCL2 protein; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of BCL2 mRNA] 2-tert-butylhydroquinone results in increased expression of BCL2 protein 2-tert-butylhydroquinone results in increased expression of BCL2 mRNA; 2-tert-butylhydroquinone results in increased expression of BCL2 protein 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in decreased expression of BCL2 protein]; 2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in decreased expression of BCL2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of BCL2 protein] |
CTD |
PMID:22275372 PMID:26878773 PMID:28583816 PMID:31423616 PMID:32565124 PMID:37075934 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bco2 |
beta-carotene oxygenase 2 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of BCO2 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of BLVRB mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of CASP3 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP3 protein] 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in increased cleavage of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; solanesol promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]] 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in increased expression of CASP3 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased cleavage of CASP3 protein] |
CTD |
PMID:22275372 PMID:25341683 PMID:25645596 PMID:26878773 PMID:28583816 PMID:31423616 PMID:32073640 PMID:32428544 PMID:32565124 PMID:35123993 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP4 protein] |
CTD |
PMID:25341683 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [Etoposide results in increased activity of CASP7 protein] |
CTD |
PMID:22275372 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Cat |
catalase |
multiple interactions increases activity |
ISO EXP |
2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of CAT mRNA] 2-tert-butylhydroquinone results in increased activity of CAT protein |
CTD |
PMID:26878773 PMID:32428544 PMID:32565124 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CBR3 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CCL2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CCL20 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases secretion |
ISO |
2-tert-butylhydroquinone results in increased secretion of CCL5 protein |
CTD |
PMID:30806763 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of CCN2 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of CCND1 protein 2-tert-butylhydroquinone promotes the reaction [sodium arsenite results in increased expression of CCND1 protein] |
CTD |
PMID:26878773 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd5l |
Cd5 molecule-like |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CD5L mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD69 protein] |
CTD |
PMID:30171972 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CD86 protein |
CTD |
PMID:19033392 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased expression of CDK4 protein] 2-tert-butylhydroquinone results in increased expression of CDK4 protein |
CTD |
PMID:26878773 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of and results in increased activity of CES1 protein alternative form; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of CES1 mRNA alternative form] |
CTD |
PMID:19715681 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
ISO |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; 2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] |
CTD |
PMID:21443188 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Creg2 |
cellular repressor of E1A-stimulated genes 2 |
affects response to substance |
ISO |
CREG2 gene SNP affects the susceptibility to 2-tert-butylhydroquinone |
CTD |
PMID:25622337 |
|
NCBI chr 9:41,872,000...41,945,413
Ensembl chr 9:41,902,304...41,945,095
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of AKT1 protein]; 2-tert-butylhydroquinone inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased secretion of HMGB1 protein]; [2-tert-butylhydroquinone co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of CSF1R protein; [2-tert-butylhydroquinone co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of HMOX1 protein; [TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of CTSK protein; [TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of NFATC1 protein |
CTD |
PMID:23112101 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
[2-tert-butylhydroquinone co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of CSF1R protein; [TNFSF11 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of CSF1R protein |
CTD |
PMID:23112101 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
[TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of CTSK protein |
CTD |
PMID:23112101 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Cul3 |
cullin 3 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to CUL3 protein] |
CTD |
PMID:18417180 PMID:30261176 |
|
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CXCL1 mRNA |
CTD |
PMID:30806763 PMID:35724838 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CXCL2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CXCL1 mRNA |
CTD |
PMID:30806763 PMID:35724838 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CYB5A mRNA |
CTD |
PMID:16014739 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased expression of CYBB protein] |
CTD |
PMID:28844481 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of CYCS protein 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin affects the localization of CYCS protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of CYCS protein] |
CTD |
PMID:31423616 PMID:35123993 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of CYP11A1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of CYP11A1 protein] |
CTD |
PMID:32565124 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases activity |
ISO |
2-tert-butylhydroquinone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; 2-tert-butylhydroquinone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; 2-tert-butylhydroquinone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; 2-tert-butylhydroquinone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; FH535 inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP1A1 mRNA]; resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased activity of CYP1A1 protein]; resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP1A1 mRNA] 2-tert-butylhydroquinone results in increased expression of and results in increased activity of CYP1A1 protein; resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased activity of CYP1A1 protein] |
CTD |
PMID:9973208 PMID:15608132 PMID:15627257 PMID:16581943 PMID:25174530 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of CYP2C19 mRNA; 2-tert-butylhydroquinone results in increased expression of CYP2C19 protein |
CTD |
PMID:24830941 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein] 2-tert-butylhydroquinone results in increased expression of DDIT3 protein |
CTD |
PMID:25341683 PMID:35724838 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dsc3 |
desmocollin 3 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of DSC3 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of DUSP1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of EDN1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [arsenite results in increased expression of and results in increased secretion of EGF protein] |
CTD |
PMID:36343453 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:25341683 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression multiple interactions |
EXP ISO |
2-tert-butylhydroquinone results in increased expression of EPHX1 mRNA 2-tert-butylhydroquinone results in increased expression of EPHX1 exon; 2-tert-butylhydroquinone results in increased expression of EPHX1 protein alternative form NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of EPHX1 exon] |
CTD |
PMID:20650352 PMID:24704207 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Esd |
esterase D |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of ESD mRNA |
CTD |
PMID:16014739 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone binds to and results in increased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
2-tert-butylhydroquinone binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
EXP |
2-tert-butylhydroquinone promotes the reaction [FGF1 protein results in increased abundance of and results in increased secretion of Glutathione]; FGF1 protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein] |
CTD |
PMID:16524372 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of FGF18 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO EXP |
2-tert-butylhydroquinone results in increased expression of FOS protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased expression of FOS protein]; 2-tert-butylhydroquinone promotes the reaction [FOS protein binds to CYP2C9 promoter] 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased expression of FOS protein] |
CTD |
PMID:24830941 PMID:28844481 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of FSHB protein] |
CTD |
PMID:32565124 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased expression of FTH1 mRNA]; PTEN protein affects the reaction [2-tert-butylhydroquinone results in increased expression of FTH1 mRNA]; wortmannin inhibits the reaction [2-tert-butylhydroquinone results in increased expression of FTH1 mRNA] |
CTD |
PMID:23829535 PMID:25003661 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of FTL1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Ftmt |
ferritin mitochondrial |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of FTMT mRNA |
CTD |
PMID:15664434 |
|
NCBI chr18:45,758,874...45,760,123
Ensembl chr18:45,758,874...45,760,123
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Streptozocin results in decreased expression of G6PD mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Streptozocin results in decreased expression of G6PD protein] |
CTD |
PMID:35478295 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabpa |
GA binding protein transcription factor subunit alpha |
affects localization |
ISO |
2-tert-butylhydroquinone affects the localization of GABPA protein |
CTD |
PMID:16308312 |
|
NCBI chr11:23,888,586...23,917,612
Ensembl chr11:23,888,815...23,917,605
|
|
G |
Gata3 |
GATA binding protein 3 |
increases activity |
ISO |
[2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased activity of GATA3 protein |
CTD |
PMID:22250088 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression increases expression increases activity multiple interactions decreases expression |
ISO EXP |
2-tert-butylhydroquinone affects the expression of GCLC mRNA 2-tert-butylhydroquinone results in increased expression of GCLC mRNA 2-tert-butylhydroquinone results in increased activity of GCLC protein 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA]; [2-tert-butylhydroquinone results in increased activity of GCLC protein] which results in increased abundance of Glutathione; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA; Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GCLC mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLC mRNA] 2-tert-butylhydroquinone results in decreased expression of GCLC mRNA |
CTD |
PMID:7955076 PMID:10978506 PMID:12007577 PMID:15946948 PMID:16014739 PMID:17980396 PMID:19183254 PMID:19328227 PMID:22250088 PMID:23906629 PMID:24128855 PMID:27178040 PMID:30547568 PMID:30806763 PMID:32428544 PMID:35724838 More...
|
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions increases expression decreases expression |
ISO EXP |
NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLM mRNA] 2-tert-butylhydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA]; [2,2',4,4'-tetrabromodiphenyl ether co-treated with 2-tert-butylhydroquinone] results in increased expression of GCLM mRNA 2-tert-butylhydroquinone results in decreased expression of GCLM mRNA |
CTD |
PMID:10978506 PMID:12007577 PMID:12081989 PMID:16014739 PMID:19183254 PMID:19328227 PMID:24632381 PMID:25003661 PMID:25305463 PMID:30547568 PMID:35724838 More...
|
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of GPR87 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [Matrines results in increased expression of GPT protein] |
CTD |
PMID:37716422 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression multiple interactions |
EXP |
2-tert-butylhydroquinone results in increased expression of GPX1 protein 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of GPX1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of GPX1 protein] |
CTD |
PMID:28583816 PMID:32565124 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases expression multiple interactions |
ISO EXP |
2-tert-butylhydroquinone results in increased expression of GPX4 mRNA; 2-tert-butylhydroquinone results in increased expression of GPX4 protein 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of GPX4 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of GPX4 protein] 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of GPX4 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of GPX4 protein] |
CTD |
PMID:37393915 PMID:37716422 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of GRIA1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity multiple interactions |
ISO EXP |
2-tert-butylhydroquinone results in increased activity of GSR protein 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased activity of GSR protein] 2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] |
CTD |
PMID:12572858 PMID:24970285 PMID:32565124 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
increases expression multiple interactions |
ISO EXP |
2-tert-butylhydroquinone results in increased expression of GSS mRNA [2-tert-butylhydroquinone co-treated with Cisplatin] results in increased expression of GSS mRNA |
CTD |
PMID:10978506 PMID:19183254 PMID:32428544 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression multiple interactions |
EXP |
2-tert-butylhydroquinone results in increased expression of GSTA2 mRNA; 2-tert-butylhydroquinone results in increased expression of GSTA2 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [2-tert-butylhydroquinone results in increased expression of GSTA2 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GSTA2]; 2-tert-butylhydroquinone inhibits the reaction [oltipraz results in increased expression of GSTA2 mRNA]; 2-tert-butylhydroquinone results in increased expression of and results in increased activity of GSTA2 protein; [S-Nitroso-N-Acetylpenicillamine co-treated with 2-tert-butylhydroquinone] results in increased expression of GSTA2; Dexamethasone promotes the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of GSTA2 protein]; Dexamethasone promotes the reaction [2-tert-butylhydroquinone results in increased expression of GSTA2 mRNA]; N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GSTA2 protein] |
CTD |
PMID:7587946 PMID:12242683 PMID:15155840 PMID:15319326 PMID:15357004 PMID:15870285 More...
|
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
2-tert-butylhydroquinone results in increased expression of GSTA5 mRNA |
CTD |
PMID:20650352 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of GSTM1 protein [2-tert-butylhydroquinone co-treated with Cisplatin] results in increased expression of GSTM1 mRNA 2-tert-butylhydroquinone results in increased expression of GSTM1 mRNA |
CTD |
PMID:21443188 PMID:32428544 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP ISO |
2-tert-butylhydroquinone results in increased expression of GSTP1 protein 2-tert-butylhydroquinone results in increased expression of GSTP1 mRNA |
CTD |
PMID:12680784 PMID:15533597 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gzmb |
granzyme B |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of GZMB protein] |
CTD |
PMID:30171972 |
|
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases expression |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of H2AX protein] 2-tert-butylhydroquinone results in increased expression of H2AX protein 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of H2AX protein] |
CTD |
PMID:28583816 PMID:35123993 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hbg1 |
hemoglobin subunit gamma 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of HBG1 mRNA |
CTD |
PMID:21464371 |
|
NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:158,271,873...158,273,425
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression |
EXP |
2-tert-butylhydroquinone results in decreased expression of HES1 protein |
CTD |
PMID:29663635 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased secretion of HMGB1 protein] |
CTD |
PMID:23112101 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO EXP |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; 2,2',4,4'-tetrabromodiphenyl ether promotes the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]; 2-tert-butylhydroquinone promotes the reaction [sodium arsenite results in increased expression of HMOX1 protein]; [2-tert-butylhydroquinone co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA; brusatol inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein]; Calcium affects the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; Calcium Chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA] 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in decreased expression of HMOX1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in decreased expression of HMOX1 protein]; 2-tert-butylhydroquinone inhibits the reaction [Paraquat results in increased expression of HMOX1 protein]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]; [2-tert-butylhydroquinone co-treated with Cisplatin] results in increased expression of HMOX1 mRNA; [2-tert-butylhydroquinone co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of HMOX1 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA; [TNFSF11 protein co-treated with 2-tert-butylhydroquinone] results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein]; Calcium Chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; HMOX1 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]]; Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA] 2-tert-butylhydroquinone inhibits the reaction [decamethrin results in increased expression of HMOX1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [decamethrin results in increased expression of HMOX1 protein]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of HMOX1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of HMOX1 protein]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of HMOX1 protein]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of HMOX1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of HMOX1 protein]; 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein]; 2-tert-butylhydroquinone promotes the reaction [thallium nitrate results in increased expression of HMOX1 protein]; [2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA]] which results in decreased susceptibility to Magnesium Chloride; FGF1 protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein]; NFE2L2 gene mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein] 2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA; 2-tert-butylhydroquinone results in increased expression of HMOX1 protein |
CTD |
PMID:8612205 PMID:10473555 PMID:10874044 PMID:10975858 PMID:16014739 PMID:16524372 PMID:17676812 PMID:18227147 PMID:18417180 PMID:18482591 PMID:18512965 PMID:19033392 PMID:19715681 PMID:21107535 PMID:21443188 PMID:22250088 PMID:22493042 PMID:22983789 PMID:23112101 PMID:23906629 PMID:23942037 PMID:23945499 PMID:24128855 PMID:24970285 PMID:25003661 PMID:25305463 PMID:26878773 PMID:26879219 PMID:27012417 PMID:28264691 PMID:28583816 PMID:28645578 PMID:29663635 PMID:30476502 PMID:30547568 PMID:31726083 PMID:32073640 PMID:32428544 PMID:33465425 PMID:35724838 PMID:37075934 PMID:37393915 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:32565124 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of HSD3B1 mRNA] |
CTD |
PMID:32565124 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of HSF1 mRNA |
CTD |
PMID:30309986 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein] |
CTD |
PMID:25341683 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]; 2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Dinoprostone]; 2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]; 2-tert-butylhydroquinone results in decreased expression of and results in decreased secretion of IFNG protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased expression of and results in decreased secretion of IFNG protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased expression of IFNG mRNA; HMOX1 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]]; NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] |
CTD |
PMID:22250088 PMID:23942037 PMID:30171972 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased expression of IKBKB protein modified form] |
CTD |
PMID:28844481 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases expression |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of IL10 mRNA] 2-tert-butylhydroquinone results in increased expression of IL10 mRNA |
CTD |
PMID:32565124 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]; 2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]] |
CTD |
PMID:25680285 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]; 2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]; 2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL23A protein binds to IL12B protein]]; 2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]] |
CTD |
PMID:25680285 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
[2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL13 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of IL13 mRNA |
CTD |
PMID:22250088 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il16 |
interleukin 16 |
increases secretion |
ISO |
2-tert-butylhydroquinone results in increased secretion of IL16 protein |
CTD |
PMID:30806763 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17d |
interleukin 17D |
multiple interactions |
ISO |
2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of IL17D protein] |
CTD |
PMID:34023435 |
|
NCBI chr15:31,671,337...31,688,833
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of IL1A mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of IL1B protein]; 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased expression of and results in increased secretion of IL1B protein] 2-tert-butylhydroquinone inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; 2-tert-butylhydroquinone inhibits the reaction [IL1B protein affects the localization of RELA protein]; 2-tert-butylhydroquinone inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; 2-tert-butylhydroquinone inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:28583816 PMID:28844481 PMID:35724838 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
decreases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in decreased expression of IL2 mRNA 2-tert-butylhydroquinone results in decreased expression of and results in decreased secretion of IL2 protein |
CTD |
PMID:23945499 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il23a |
interleukin 23 subunit alpha |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL23A protein binds to IL12B protein]] |
CTD |
PMID:25680285 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in decreased expression of IL2RA mRNA; 2-tert-butylhydroquinone results in decreased expression of IL2RA protein 2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RA protein] |
CTD |
PMID:23945499 PMID:30171972 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL4 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of IL4 mRNA 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of IL4 protein] |
CTD |
PMID:22250088 PMID:34023435 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
[2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL5 protein |
CTD |
PMID:22250088 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
2-tert-butylhydroquinone inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased secretion of IL6 protein]; 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of IL6 protein] 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased expression of and results in increased secretion of IL6 protein] |
CTD |
PMID:25305463 PMID:28844481 PMID:34023435 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases phosphorylation |
ISO |
2-tert-butylhydroquinone promotes the reaction [JUND protein binds to CYP2C9 promoter]; 2-tert-butylhydroquinone promotes the reaction [JUND protein modified form binds to CYP2C9 promoter]; JUND mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA]; pyrazolanthrone inhibits the reaction [2-tert-butylhydroquinone results in increased phosphorylation of JUND protein] |
CTD |
PMID:24830941 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kdr |
kinase insert domain receptor |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of KDR protein [cyanoginosin LR co-treated with 2-tert-butylhydroquinone] results in increased expression of KDR protein |
CTD |
PMID:36206955 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions increases expression decreases response to substance affects binding |
ISO EXP |
2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to CUL3 protein]; 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [KEAP1 protein binds to NFE2L2 protein]; KEAP1 protein mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein]; KEAP1 protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein] 2-tert-butylhydroquinone promotes the reaction [thallium nitrate results in decreased expression of KEAP1 protein] 2-tert-butylhydroquinone results in increased expression of KEAP1 protein KEAP1 protein mutant form results in decreased susceptibility to 2-tert-butylhydroquinone 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of KEAP1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of KEAP1 protein]; 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to CUL3 protein]; 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]; [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein]; [2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] which results in increased activity of NFE2L2 protein; Cadmium Chloride inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]] 2-tert-butylhydroquinone binds to KEAP1 protein |
CTD |
PMID:18417180 PMID:18512965 PMID:19033392 PMID:19808700 PMID:23589329 PMID:30261176 PMID:31368498 PMID:31726083 PMID:32073640 More...
|
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of LHB protein] |
CTD |
PMID:32565124 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mafg |
MAF bZIP transcription factor G |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of MAFG mRNA |
CTD |
PMID:35724838 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased phosphorylation of MAPK1 protein]; 2-tert-butylhydroquinone inhibits the reaction [arsenite results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:24830941 PMID:36343453 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased phosphorylation of MAPK3 protein]; 2-tert-butylhydroquinone inhibits the reaction [arsenite results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:24830941 PMID:36343453 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of MCHR1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
|
|
G |
Mfn2 |
mitofusin 2 |
multiple interactions increases expression |
EXP |
2-tert-butylhydroquinone inhibits the reaction [thallium nitrate results in decreased expression of MFN2 protein] 2-tert-butylhydroquinone results in increased expression of MFN2 protein |
CTD |
PMID:31726083 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone promotes the reaction [Cycloheximide results in increased expression of MT1 mRNA]; Cycloheximide promotes the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]; Edetic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]; Edetic Acid inhibits the reaction [zinc chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]]; MTF1 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]; zinc chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]; Zinc deficiency inhibits the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA] |
CTD |
PMID:14998373 PMID:19276070 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of MT2 mRNA |
CTD |
PMID:14998373 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtf1 |
metal-regulatory transcription factor 1 |
multiple interactions |
ISO |
MTF1 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA] |
CTD |
PMID:14998373 |
|
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
|
|
G |
Mtrf1 |
mitochondrial translation release factor 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of MTRF1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr15:54,776,885...54,804,699
Ensembl chr15:54,776,937...54,804,704
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
[TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of NFATC1 protein |
CTD |
PMID:23112101 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of NFE2L1 protein |
CTD |
PMID:33838154 |
|
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects binding increases expression increases stability increases ubiquitination decreases response to substance increases activity affects response to substance affects localization increases response to substance |
ISO EXP |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]; 2-tert-butylhydroquinone affects the localization of and results in increased activity of NFE2L2 protein; 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in decreased expression of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [arsenite results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [KEAP1 protein binds to NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to NQO1 promoter]; 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; 2-tert-butylhydroquinone results in increased expression of and affects the localization of NFE2L2 protein; 2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein; 2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased susceptibility to arsenite; [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine; brusatol inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]; ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein]; KEAP1 protein mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein]; KEAP1 protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein]; Metformin inhibits the reaction [2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein]; NFE2L2 affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of EPHX1 exon]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of CES1 mRNA alternative form] 2-tert-butylhydroquinone binds to NFE2L2 protein 2-tert-butylhydroquinone results in increased expression of NFE2L2 mRNA; 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein 2-tert-butylhydroquinone results in increased stability of NFE2L2 protein 2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein NFE2L2 protein results in decreased susceptibility to 2-tert-butylhydroquinone 2-tert-butylhydroquinone affects the localization of and results in increased activity of NFE2L2 protein; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of NFE2L2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in decreased expression of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone results in increased expression of and results in increased localization of NFE2L2 protein; [2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA]] which results in decreased susceptibility to Magnesium Chloride; [thallium nitrate co-treated with 2-tert-butylhydroquinone] results in increased expression of NFE2L2 protein; decamethrin inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein]; N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased localization of NFE2L2 protein]; NFE2L2 gene mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein] 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased activity of GATA3 protein 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in decreased expression of NFE2L2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in decreased expression of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin affects the expression of and affects the localization of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to BCL2 promoter]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]; 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to NQO1 promoter]; 2-tert-butylhydroquinone results in increased expression of and affects the localization of NFE2L2 protein; [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein]; [2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] which results in increased activity of NFE2L2 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased activity of TBX21 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased expression of and results in decreased secretion of IFNG protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased expression of IFNG mRNA; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL13 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL4 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL5 protein; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of IL13 mRNA; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of IL4 mRNA; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA; [2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in decreased expression of BAX protein; [2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in increased expression of BCL2 protein; [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 2-tert-butylhydroquinone] results in increased expression of NFE2L2 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein]; Cadmium Chloride inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of BCL2 mRNA]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLC mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]]; NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] NFE2L2 protein affects the susceptibility to 2-tert-butylhydroquinone 2-tert-butylhydroquinone affects the localization of NFE2L2 protein NFE2L2 protein mutant form results in increased susceptibility to 2-tert-butylhydroquinone |
CTD |
PMID:10473555 PMID:10874044 PMID:12446695 PMID:14510636 PMID:14998373 PMID:15319326 PMID:15870285 PMID:16092930 PMID:17676812 PMID:18417180 PMID:18512965 PMID:18852027 PMID:19033392 PMID:19183254 PMID:19276070 PMID:19328227 PMID:19715681 PMID:19786557 PMID:20554019 PMID:20932822 PMID:21107535 PMID:21443188 PMID:21464371 PMID:22250088 PMID:22275372 PMID:22476201 PMID:22684020 PMID:22746536 PMID:22983789 PMID:23589329 PMID:23707609 PMID:23906629 PMID:23942037 PMID:23945499 PMID:24704207 PMID:25003661 PMID:25341683 PMID:25680285 PMID:26878773 PMID:26879219 PMID:26958860 PMID:27012417 PMID:28583816 PMID:28645578 PMID:28790194 PMID:28844481 PMID:29663635 PMID:29857117 PMID:30476502 PMID:30806763 PMID:31368498 PMID:31423616 PMID:31726083 PMID:32073640 PMID:32428544 PMID:32565124 PMID:33465425 PMID:33838154 PMID:34023435 PMID:35123993 PMID:35478295 PMID:35724838 PMID:36343453 PMID:36786954 PMID:37075934 PMID:37393915 PMID:37716422 More...
|
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased phosphorylation of NFKBIA protein] 2-tert-butylhydroquinone inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein affects the localization of NFKBIA protein] |
CTD |
PMID:28583816 PMID:35724838 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nkd1 |
NKD inhibitor of WNT signaling pathway 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of NKD1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of NOS2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of NOS2 protein] |
CTD |
PMID:32073640 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
EXP |
2-tert-butylhydroquinone results in decreased expression of NOTCH1 protein |
CTD |
PMID:29663635 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity multiple interactions increases expression decreases expression |
ISO EXP |
2-tert-butylhydroquinone results in increased activity of NQO1 protein 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to NQO1 promoter]; 2-tert-butylhydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of NQO1 mRNA]; [lipopolysaccharide, E coli O55-B5 co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 mRNA; [sodium arsenite co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 mRNA; [sodium arsenite co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 protein; Acetylcysteine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 protein]; NFE2L2 affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 mRNA] 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of NQO1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of NQO1 protein]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NQO1 protein]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of NQO1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of NQO1 protein]; 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 protein]; 2-tert-butylhydroquinone results in increased expression of and results in increased activity of NQO1 protein; [thallium nitrate co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 protein; Dexamethasone inhibits the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NQO1 protein]; Dexamethasone inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] 2-tert-butylhydroquinone results in increased expression of NQO1 mRNA; 2-tert-butylhydroquinone results in increased expression of NQO1 protein 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to NQO1 promoter]; [2-tert-butylhydroquinone co-treated with Cisplatin] results in increased expression of NQO1 mRNA; [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA; AG-879 inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; Cycloheximide inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; Paraquat inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; Zinc promotes the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] 2-tert-butylhydroquinone results in decreased expression of NQO1 mRNA |
CTD |
PMID:7587946 PMID:9029048 PMID:11163336 PMID:14510636 PMID:14998373 PMID:15627257 PMID:16014739 PMID:16600132 PMID:17980396 PMID:18417180 PMID:18512965 PMID:19033392 PMID:19276070 PMID:20650352 PMID:21464371 PMID:22250088 PMID:22275372 PMID:22493042 PMID:23056183 PMID:23906629 PMID:23945499 PMID:24128855 PMID:24632381 PMID:24646717 PMID:24704207 PMID:24970285 PMID:25003661 PMID:25680285 PMID:26878773 PMID:28264691 PMID:28583816 PMID:28645578 PMID:29663635 PMID:30476502 PMID:30547568 PMID:30806763 PMID:31368498 PMID:31726083 PMID:32428544 PMID:35724838 PMID:37075934 PMID:37393915 More...
|
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
2-tert-butylhydroquinone binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
2-tert-butylhydroquinone binds to and results in decreased activity of NR1I3 protein alternative form |
CTD |
PMID:20869355 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of OLR1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in increased cleavage of PARP1 protein] |
CTD |
PMID:31423616 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of PCNA protein] |
CTD |
PMID:32565124 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of PDGFB mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of PGD mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of PRDX1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prf1 |
perforin 1 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PRF1 protein] |
CTD |
PMID:30171972 |
|
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of PRKACA mRNA |
CTD |
PMID:16014739 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkag2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of PRKAG2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
|
|
G |
Procr |
protein C receptor |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of PROCR mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
ISO |
PTEN protein affects the reaction [2-tert-butylhydroquinone results in increased expression of FTH1 mRNA] |
CTD |
PMID:23829535 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of PTGR1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [Emodin results in increased expression of PTGS2 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of PTGS2 protein] 2-tert-butylhydroquinone inhibits the reaction [Matrines results in increased expression of PTGS2 mRNA] |
CTD |
PMID:28583816 PMID:37393915 PMID:37716422 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of REL mRNA |
CTD |
PMID:16014739 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases phosphorylation |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in increased expression of RELA mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate affects the localization of RELA protein]; 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased activity of RELA protein] 2-tert-butylhydroquinone results in decreased phosphorylation of RELA protein 2-tert-butylhydroquinone inhibits the reaction [arsenite results in increased phosphorylation of RELA protein]; 2-tert-butylhydroquinone inhibits the reaction [IL1B protein affects the localization of RELA protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein affects the localization of RELA protein] 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of RELA mRNA]; 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of RELA protein]; 2-tert-butylhydroquinone promotes the reaction [Particulate Matter results in decreased phosphorylation of RELA protein] |
CTD |
PMID:28583816 PMID:28844481 PMID:32073640 PMID:32565124 PMID:35724838 PMID:36343453 PMID:36786954 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rorc |
RAR-related orphan receptor C |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of RORC mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of SLC3A2 mRNA |
CTD |
PMID:19183254 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of SLC40A1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of SLC7A11 mRNA 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of SLC7A11 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of SLC7A11 protein] 2-tert-butylhydroquinone results in increased expression of SLC7A11 mRNA; 2-tert-butylhydroquinone results in increased expression of SLC7A11 protein |
CTD |
PMID:19183254 PMID:37716422 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of SOD1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in decreased expression of SOD1 protein] |
CTD |
PMID:28844481 PMID:32565124 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression multiple interactions |
ISO |
2-tert-butylhydroquinone results in increased expression of SOD2 mRNA [2-tert-butylhydroquinone co-treated with Cisplatin] results in increased expression of SOD2 mRNA 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin affects the expression of SOD2 protein] 2-tert-butylhydroquinone results in increased expression of SOD2 protein |
CTD |
PMID:31423616 PMID:32428544 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sp1 |
Sp1 transcription factor |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of SP1 protein |
CTD |
PMID:36206955 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sqor |
sulfide quinone oxidoreductase |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of SQOR mRNA |
CTD |
PMID:16014739 |
|
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
2-tert-butylhydroquinone results in increased expression of SQSTM1 protein [thallium nitrate co-treated with 2-tert-butylhydroquinone] results in increased expression of SQSTM1 protein 2-tert-butylhydroquinone results in decreased expression of SQSTM1 mRNA |
CTD |
PMID:23589329 PMID:31726083 PMID:35724838 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[TNFSF11 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of SRC protein |
CTD |
PMID:23112101 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression decreases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of SRXN1 mRNA 2-tert-butylhydroquinone results in increased expression of SRXN1 protein 2-tert-butylhydroquinone results in decreased expression of SRXN1 mRNA |
CTD |
PMID:16014739 PMID:22003191 PMID:35724838 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of STAR mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of STAR protein] |
CTD |
PMID:32565124 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of TAP1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tbx21 |
T-box transcription factor 21 |
multiple interactions |
ISO |
[2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased activity of TBX21 protein |
CTD |
PMID:22250088 |
|
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [arsenite results in increased expression of and results in increased secretion of TGFA protein] |
CTD |
PMID:36343453 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
2-tert-butylhydroquinone binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in increased expression of TNF mRNA]; 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of TNF protein] 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of TNF mRNA]; 2-tert-butylhydroquinone inhibits the reaction [2,2-dichloroacetyl chloride results in increased expression of TNF protein] 2-tert-butylhydroquinone inhibits the reaction [TNF protein affects the localization of NFKBIA protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein affects the localization of RELA protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:28583816 PMID:32073640 PMID:32565124 PMID:35724838 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] 2-tert-butylhydroquinone results in increased expression of TNFAIP3 mRNA; 2-tert-butylhydroquinone results in increased expression of TNFAIP3 protein |
CTD |
PMID:35724838 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf9 |
TNF receptor superfamily member 9 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of TNFRSF9 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
2-tert-butylhydroquinone inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of AKT1 protein]; 2-tert-butylhydroquinone inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased secretion of HMGB1 protein]; [2-tert-butylhydroquinone co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of CSF1R protein; [2-tert-butylhydroquinone co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of HMOX1 protein; [TNFSF11 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of CSF1R protein; [TNFSF11 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of SRC protein; [TNFSF11 protein co-treated with 2-tert-butylhydroquinone] results in increased expression of HMOX1 protein; [TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of CTSK protein; [TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of NFATC1 protein |
CTD |
PMID:23112101 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tob1 |
transducer of ErbB-2.1 |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of TOB1 mRNA |
CTD |
PMID:16014739 |
|
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO EXP |
2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of TP53 protein] 2-tert-butylhydroquinone results in increased expression of TP53 protein 2-tert-butylhydroquinone inhibits the reaction [Emodin results in increased expression of TP53 protein] |
CTD |
PMID:35123993 PMID:37393915 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of TRIB3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression decreases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of TXNRD1 mRNA 2-tert-butylhydroquinone results in decreased expression of TXNRD1 mRNA |
CTD |
PMID:12949356 PMID:16014739 PMID:30806763 PMID:35724838 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
EXP |
2-tert-butylhydroquinone results in increased expression of UGT1A1 mRNA |
CTD |
PMID:20650352 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression multiple interactions increases activity |
EXP ISO |
2-tert-butylhydroquinone results in increased expression of UGT1A6 mRNA AHR protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of UGT1A6 mRNA] 2-tert-butylhydroquinone results in increased activity of UGT1A6 protein |
CTD |
PMID:10220484 PMID:12948865 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of UGT1A9 mRNA |
CTD |
PMID:10220484 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of UGT2B7 mRNA |
CTD |
PMID:10220484 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
increases expression |
ISO |
2-tert-butylhydroquinone results in increased expression of VCAM1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
2-tert-butylhydroquinone results in decreased expression of VEGFA mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone inhibits the reaction [Diclofenac results in increased activity of CASP3 protein] |
CTD |
PMID:14599462 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Dhodh |
dihydroorotate dehydrogenase |
increases metabolic processing multiple interactions |
EXP |
DHODH protein results in increased metabolism of 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone teriflunomide inhibits the reaction [DHODH protein results in increased metabolism of 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone] |
CTD |
PMID:9802339 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
dephostatin promotes the reaction [[Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased activity of RAF1 protein] |
CTD |
PMID:14623285 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
|
G |
A4galt |
alpha 1,4-galactosyltransferase |
decreases expression |
ISO |
hydroquinone results in decreased expression of A4GALT mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:114,368,525...114,392,872
Ensembl chr 7:114,368,276...114,396,071
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
multiple interactions increases expression increases ADP-ribosylation |
ISO |
PARP1 protein affects the reaction [hydroquinone results in increased expression of AATF protein] hydroquinone results in increased ADP-ribosylation of AATF protein |
CTD |
PMID:26822515 |
|
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO |
hydroquinone results in increased expression of ABCC3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ACE2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of ADAM17 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of ADAM17 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA]; ADAM17 protein affects the reaction [hydroquinone results in increased secretion of TNF protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; MIR122 mRNA affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; MIR122 mRNA affects the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased expression of ADAM17 protein]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA] |
CTD |
PMID:23791922 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
increases expression |
ISO |
hydroquinone results in increased expression of ADAP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
|
|
G |
Adarb2 |
adenosine deaminase RNA specific B2 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Estradiol results in increased expression of ADARB2 mRNA] |
CTD |
PMID:28704378 |
|
NCBI chr17:61,750,437...62,300,984
Ensembl chr17:61,756,067...62,300,831
|
|
G |
Adprh |
ADP-ribosylarginine hydrolase |
increases expression |
ISO |
hydroquinone results in increased expression of ADPRH mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
increases expression |
ISO |
hydroquinone results in increased expression of ADTRP mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
hydroquinone results in increased expression of AEN mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Afap1 |
actin filament associated protein 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of AFAP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:74,743,322...74,856,300
Ensembl chr14:74,743,320...74,856,263
|
|
G |
Aggf1 |
angiogenic factor with G patch and FHA domains 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of AGGF1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:26,619,336...26,646,050
Ensembl chr 2:26,619,339...26,645,952
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects localization multiple interactions increases expression |
ISO EXP |
hydroquinone affects the localization of AHR protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of and affects the localization of AHR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of AHR protein]; hydroquinone results in increased expression of and affects the localization of AHR protein alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of AHR protein] |
CTD |
PMID:15935814 PMID:29935983 PMID:35123993 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm2 |
AIF family member 2 |
increases expression |
ISO |
hydroquinone results in increased expression of AIFM2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases expression |
ISO |
hydroquinone results in decreased expression of AKR1B10 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
hydroquinone inhibits the reaction [AKT1 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of AKT1 protein]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:17464197 PMID:28883758 PMID:37148176 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [AKT2 protein results in increased phosphorylation of IRF3 protein] |
CTD |
PMID:28883758 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [AKT3 protein results in increased phosphorylation of IRF3 protein] |
CTD |
PMID:28883758 |
|
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
ALB protein binds to and affects the transport of hydroquinone |
CTD |
PMID:8831264 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
increases expression |
ISO |
hydroquinone results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
increases expression |
ISO |
hydroquinone results in increased expression of ALDH2 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO |
hydroquinone results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
increases expression |
ISO |
hydroquinone results in increased expression of ALOX12 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
increases expression |
ISO |
hydroquinone results in increased expression of ALOX12B mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:53,863,060...53,874,938
Ensembl chr10:53,863,060...53,874,938
|
|
G |
Aloxe3 |
arachidonate epidermal lipoxygenase 3 |
increases expression |
ISO |
hydroquinone results in increased expression of ALOXE3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:53,830,219...53,854,328
Ensembl chr10:53,831,264...53,854,328
|
|
G |
Alpk1 |
alpha-kinase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of ALPK1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
increases expression |
ISO |
hydroquinone results in increased expression of AMBP mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
decreases expression |
ISO |
hydroquinone results in decreased expression of ANKDD1A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
hydroquinone results in increased expression of ANXA1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
hydroquinone results in increased expression of ANXA3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Apoe |
apolipoprotein E |
decreases expression multiple interactions |
EXP |
hydroquinone results in decreased expression of APOE mRNA [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of APOE mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of APOE mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of APOE mRNA] |
CTD |
PMID:33188856 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
[KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of APP mRNA |
CTD |
PMID:37245849 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
decreases expression |
ISO |
hydroquinone results in decreased expression of AQP3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Arg1 |
arginase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of ARG1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
hydroquinone results in increased expression of ARG2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap27 |
Rho GTPase activating protein 27 |
increases expression |
ISO |
hydroquinone results in increased expression of ARHGAP27 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:88,280,470...88,313,225
Ensembl chr10:88,280,455...88,313,185
|
|
G |
Arhgap42 |
Rho GTPase activating protein 42 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ARHGAP42 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:6,154,759...6,384,497
Ensembl chr 8:6,156,865...6,384,870
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
affects expression |
ISO |
hydroquinone affects the expression of ARHGDIA protein |
CTD |
PMID:17181942 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
ISO |
hydroquinone results in increased expression of ARHGEF2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arhgef26 |
Rho guanine nucleotide exchange factor 26 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ARHGEF26 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819
|
|
G |
Arl3 |
ARF like GTPase 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ARL3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:245,400,659...245,446,673
Ensembl chr 1:245,400,550...245,446,820
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of ARNT protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ARNT protein] |
CTD |
PMID:35123993 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
hydroquinone results in increased expression of ASNS mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
increases expression |
ISO |
hydroquinone results in increased expression of ASPRV1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:119,077,415...119,078,887
Ensembl chr 4:119,077,356...119,078,379
|
|
G |
Atf2 |
activating transcription factor 2 |
increases phosphorylation multiple interactions |
ISO |
hydroquinone results in increased phosphorylation of ATF2 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of ATF2 protein]; ATF2 protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of TNF protein]; hydroquinone promotes the reaction [ATF2 protein binds to MIR122 promoter]; hydroquinone promotes the reaction [ATF2 protein binds to PPP2CA promoter]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:23288922 PMID:23791922 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
hydroquinone results in increased expression of ATF3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
hydroquinone results in increased expression of ATF4 mRNA; hydroquinone results in increased expression of ATF4 protein |
CTD |
PMID:15452088 PMID:24053669 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions decreases expression increases expression |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; [Sirolimus co-treated with hydroquinone] results in decreased expression of ATF6 protein; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; ATF6 protein affects the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; ATF6 protein affects the reaction [hydroquinone results in increased expression of BAX protein]; ATF6 protein affects the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein] hydroquinone results in decreased expression of ATF6 mRNA; hydroquinone results in decreased expression of ATF6 protein |
CTD |
PMID:36646296 PMID:37148176 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
hydroquinone results in increased expression of ATG12 protein |
CTD |
PMID:37148176 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions increases expression |
ISO |
PARP1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mRNA]; SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of ATG5 mRNA] |
CTD |
PMID:28263894 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
increases expression |
ISO |
hydroquinone results in increased expression of ATG7 protein |
CTD |
PMID:35302183 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atp2c2 |
ATPase secretory pathway Ca2+ transporting 2 |
increases expression |
ISO |
hydroquinone results in increased expression of ATP2C2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:47,754,120...47,811,369
Ensembl chr19:47,754,120...47,811,368
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
ISO |
hydroquinone results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
increases expression |
ISO |
hydroquinone results in increased expression of AZGP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
multiple interactions decreases expression affects localization |
ISO |
[ferric chloride results in increased oxidation of hydroquinone] promotes the reaction [hydroquinone analog binds to BACH1 protein]; hydroquinone promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of BACH1 protein] hydroquinone results in decreased expression of BACH1 protein hydroquinone affects the localization of BACH1 protein |
CTD |
PMID:23290930 PMID:28645578 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases expression |
ISO |
hydroquinone results in decreased expression of BAD mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag1 |
BAG cochaperone 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of BAG1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
increases expression |
ISO |
hydroquinone results in increased expression of BAMBI mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression increases expression multiple interactions |
ISO |
hydroquinone results in decreased expression of BAX protein hydroquinone results in increased expression of BAX protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of BAX protein]; 4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [hydroquinone results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of BAX protein]; [ABT-737 co-treated with hydroquinone] results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of BAX protein]; ATF6 protein affects the reaction [hydroquinone results in increased expression of BAX protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of BAX protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of BAX protein]; Sirolimus promotes the reaction [hydroquinone results in increased expression of BAX protein] |
CTD |
PMID:27515134 PMID:27606422 PMID:28843007 PMID:33771647 PMID:33932074 PMID:35123993 PMID:35561756 PMID:37148176 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
hydroquinone results in increased expression of BBC3 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl11a |
BCL11 transcription factor A |
decreases expression |
ISO |
hydroquinone results in decreased expression of BCL11A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl11b |
BCL11 transcription factor B |
decreases expression |
ISO |
hydroquinone results in decreased expression of BCL11B mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:126,834,531...126,927,720
Ensembl chr 6:126,834,531...126,928,224
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression increases expression |
ISO |
[PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein; [PARP1 protein co-treated with hydroquinone] results in increased expression of BCL2 protein; CDKN2A protein affects the reaction [hydroquinone results in increased expression of BCL2 protein]; PARP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 protein] hydroquinone results in decreased expression of BCL2 mRNA; hydroquinone results in decreased expression of BCL2 protein hydroquinone promotes the reaction [XBP1 protein affects the expression of BCL2 mRNA]; XBP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 mRNA] hydroquinone results in increased expression of BCL2 mRNA; hydroquinone results in increased expression of BCL2 protein |
CTD |
PMID:23288922 PMID:24053669 PMID:27515134 PMID:27606422 PMID:28444915 PMID:28843007 PMID:28983606 PMID:33771647 PMID:33932074 PMID:35123993 PMID:35561756 PMID:37148176 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression increases expression |
ISO |
hydroquinone results in decreased expression of BCL2L1 protein hydroquinone results in increased expression of BCL2L1 protein |
CTD |
PMID:23288922 PMID:35561756 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of BDH2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Becn1 |
beclin 1 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of BECN1 mRNA; hydroquinone results in increased expression of BECN1 protein PARP1 protein promotes the reaction [hydroquinone results in increased expression of BECN1 mRNA]; SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of BECN1 mRNA] |
CTD |
PMID:28263894 PMID:35302183 PMID:37148176 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases cleavage multiple interactions |
ISO |
hydroquinone results in increased cleavage of BID protein FADD protein affects the reaction [hydroquinone results in increased cleavage of BID protein] |
CTD |
PMID:23288922 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression decreases expression |
ISO |
hydroquinone results in increased expression of BIRC3 mRNA hydroquinone results in decreased expression of BIRC3 mRNA |
CTD |
PMID:15452088 PMID:31256213 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression multiple interactions |
ISO |
hydroquinone results in decreased expression of BIRC5 protein Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of BIRC5 protein] |
CTD |
PMID:28886972 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of BNIP3 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bora |
bora, aurora kinase A activator |
decreases expression |
ISO |
hydroquinone results in decreased expression of BORA mRNA |
CTD |
PMID:23416264 |
|
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
|
|
G |
Bpifc |
BPI fold containing family C |
increases expression |
ISO |
hydroquinone results in increased expression of BPIFC mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:17,848,787...17,905,993
Ensembl chr 7:17,861,007...17,905,919
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
ISO |
hydroquinone results in increased expression of BRCA1 protein |
CTD |
PMID:29421518 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of BST2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
hydroquinone results in increased expression of BTG2 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Btrc |
beta-transducin repeat containing E3 ubiquitin protein ligase |
multiple interactions |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC protein]; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC protein; BTRC protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]; BTRC protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of SP1 protein]; Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA]; Dactinomycin promotes the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA] |
CTD |
PMID:35561756 |
|
NCBI chr 1:244,210,299...244,380,126
Ensembl chr 1:244,210,314...244,376,721
|
|
G |
Bub3 |
BUB3 mitotic checkpoint protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of BUB3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:186,330,358...186,340,969
Ensembl chr 1:186,327,931...186,395,036
|
|
G |
C19h16orf74 |
similar to human chromosome 16 open reading frame 74 |
increases expression |
ISO |
hydroquinone results in increased expression of C16ORF74 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:48,660,288...48,686,287
Ensembl chr19:48,660,288...48,686,349
|
|
G |
C3h15orf48 |
similar to human chromosome 15 open reading frame 48 |
increases expression |
ISO |
hydroquinone results in increased expression of C15ORF48 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:109,719,952...109,723,505
Ensembl chr 3:109,719,897...109,724,006 Ensembl chr 3:109,719,897...109,724,006
|
|
G |
Calb2 |
calbindin 2 |
increases expression |
ISO |
hydroquinone results in increased expression of CALB2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Calcb |
calcitonin-related polypeptide, beta |
increases expression |
ISO |
hydroquinone results in increased expression of CALCB mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125
|
|
G |
Calhm6 |
calcium homeostasis modulator family member 6 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CALHM6 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
|
|
G |
Calml3 |
calmodulin-like 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CALML3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Capn2 |
calpain 2 |
decreases activity |
ISO |
hydroquinone results in decreased activity of CAPN2 protein |
CTD |
PMID:9118890 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CA3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CA9 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp1 |
caspase 1 |
increases cleavage multiple interactions |
ISO |
hydroquinone results in increased cleavage of CASP1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein] |
CTD |
PMID:36646296 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of CASP12 protein] |
CTD |
PMID:36646296 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases degradation increases cleavage increases expression decreases activity decreases expression |
ISO EXP |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of and affects the activity of CASP3 protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein]; hydroquinone results in decreased expression of and results in increased cleavage of CASP3 protein; IGF1 protein inhibits the reaction [hydroquinone results in increased expression of CASP3 protein modified form]; Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP3 protein modified form]; NOX4 protein promotes the reaction [hydroquinone results in increased degradation of CASP3 protein]; Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; PARP1 protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein] hydroquinone results in decreased activity of CASP3 protein [hydroquinone results in increased abundance of Reactive Oxygen Species] which results in decreased activity of CASP3 protein hydroquinone results in decreased expression of CASP3 mRNA; hydroquinone results in decreased expression of CASP3 protein |
CTD |
PMID:15337166 PMID:15452088 PMID:15777082 PMID:15816534 PMID:20946948 PMID:22302391 PMID:22960397 PMID:23288922 PMID:23776099 PMID:24053669 PMID:26056850 PMID:26335980 PMID:27515134 PMID:27606422 PMID:28444915 PMID:28886972 PMID:28983606 PMID:35123993 PMID:35302183 PMID:37148176 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases cleavage |
ISO |
hydroquinone results in increased cleavage of CASP4 protein |
CTD |
PMID:24053669 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CASP6 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases cleavage increases expression decreases activity multiple interactions |
ISO |
hydroquinone results in increased cleavage of CASP7 protein hydroquinone results in increased expression of CASP7 protein modified form hydroquinone results in decreased activity of CASP7 protein Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP7 protein modified form]; WRN protein inhibits the reaction [hydroquinone results in increased cleavage of CASP7 protein] |
CTD |
PMID:19064679 PMID:22960397 PMID:28886972 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage increases expression increases activity |
ISO |
FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein]; MPO protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein]; Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP8 protein] hydroquinone results in increased expression of CASP8 protein hydroquinone results in increased activity of CASP8 protein |
CTD |
PMID:15777082 PMID:23288922 PMID:23776099 PMID:27606422 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
decreases expression increases activity increases expression multiple interactions increases cleavage |
ISO EXP |
hydroquinone results in decreased expression of CASP9 mRNA; hydroquinone results in decreased expression of CASP9 protein hydroquinone results in increased activity of CASP9 protein hydroquinone results in increased expression of CASP9 protein Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP9 protein modified form]; Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP9 protein] |
CTD |
PMID:15452088 PMID:15777082 PMID:15816534 PMID:20946948 PMID:22302391 PMID:23288922 PMID:23776099 PMID:26056850 PMID:27606422 PMID:28886972 PMID:37148176 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases response to substance decreases activity |
ISO EXP |
CAT protein results in decreased susceptibility to hydroquinone hydroquinone results in decreased activity of CAT protein |
CTD |
PMID:10193577 PMID:26056850 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin2 |
caveolae associated protein 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CAVIN2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
|
|
G |
Cbs |
cystathionine beta synthase |
increases expression |
ISO |
hydroquinone results in increased expression of CBS mRNA |
CTD |
PMID:31256213 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccdc127 |
coiled-coil domain containing 127 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CCDC127 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:28,928,420...28,935,885
Ensembl chr 1:28,928,325...28,935,893
|
|
G |
Ccdc163 |
coiled-coil domain containing 163 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CCDC163 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:130,172,014...130,178,934
Ensembl chr 5:130,172,774...130,178,929
|
|
G |
Ccdc8 |
coiled-coil domain containing 8 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CCDC8 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:77,679,521...77,682,849
Ensembl chr 1:77,679,218...77,683,090
|
|
G |
Ccdc88c |
coiled-coil domain containing 88C |
decreases expression |
ISO |
hydroquinone results in decreased expression of CCDC88C mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:120,169,752...120,289,459
Ensembl chr 6:120,169,738...120,289,555
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
hydroquinone results in increased expression of CCL11 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases secretion decreases expression multiple interactions increases secretion increases expression |
ISO |
hydroquinone results in decreased secretion of CCL2 protein hydroquinone results in decreased expression of CCL2 mRNA hydroquinone inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]; hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of CCL2 protein] hydroquinone results in increased secretion of CCL2 protein hydroquinone results in increased expression of CCL2 protein |
CTD |
PMID:17572062 PMID:20946948 PMID:22302391 PMID:22465845 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
hydroquinone results in increased expression of CCL3 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
hydroquinone results in increased expression of CCL4 protein |
CTD |
PMID:17572062 PMID:18353026 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
hydroquinone results in increased expression of CCL5 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
affects expression |
ISO |
hydroquinone affects the expression of CCN1 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
ISO |
hydroquinone results in increased expression of CCN2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna1 |
cyclin A1 |
increases expression |
ISO |
hydroquinone results in increased expression of CCNA1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression decreases expression |
ISO |
Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of CCND1 protein]; MIR7-2 promotes the reaction [hydroquinone results in increased expression of CCND1 protein] hydroquinone results in increased expression of CCND1 mRNA; hydroquinone results in increased expression of CCND1 protein |
CTD |
PMID:28886972 PMID:33932074 PMID:37951342 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of CCNE1 protein MIR7-2 promotes the reaction [hydroquinone results in increased expression of CCNE1 protein] |
CTD |
PMID:37951342 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
hydroquinone results in increased expression of CCNE2 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
hydroquinone results in decreased expression of CCNF mRNA |
CTD |
PMID:23416264 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccsap |
centriole, cilia and spindle-associated protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of CCSAP mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:51,824,954...51,843,469
Ensembl chr19:51,826,994...51,842,753
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CD69 protein] |
CTD |
PMID:20054000 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd80 |
Cd80 molecule |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein] |
CTD |
PMID:19148301 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd86 |
CD86 molecule |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of CD86 protein hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein] |
CTD |
PMID:19148301 PMID:19665512 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CDCA2 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca7 |
cell division cycle associated 7 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CDCA7 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdh26 |
cadherin 26 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CDH26 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:165,520,523...165,573,191
Ensembl chr 3:165,520,439...165,572,149
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions increases expression |
ISO |
MIR7-2 promotes the reaction [hydroquinone results in increased expression of CDK2 protein] |
CTD |
PMID:37951342 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions increases expression |
ISO |
MIR7-2 promotes the reaction [hydroquinone results in increased expression of CDK4 protein] |
CTD |
PMID:37951342 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of CDKN1A mRNA; hydroquinone results in increased expression of CDKN1A protein SIRT1 protein affects the reaction [hydroquinone results in increased expression of CDKN1A protein] |
CTD |
PMID:23416264 PMID:27515134 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
hydroquinone results in decreased expression of CDKN1C mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions decreases expression |
ISO |
CDKN2A protein affects the reaction [hydroquinone results in decreased expression of BAX protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of RB1 protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of TP53 protein]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of BCL2 protein]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of MMP9 mRNA]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of MMP9 protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of CDKN2A protein] hydroquinone results in decreased expression of CDKN2A mRNA; hydroquinone results in decreased expression of CDKN2A protein |
CTD |
PMID:33771647 PMID:33932074 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdsn |
corneodesmosin |
increases expression |
ISO |
hydroquinone results in increased expression of CDSN mRNA |
CTD |
PMID:31256213 |
|
NCBI chr20:3,179,432...3,184,252
Ensembl chr20:3,179,438...3,184,250
|
|
G |
Cemip |
cell migration inducing hyaluronidase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of CEMIP mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
hydroquinone results in decreased expression of CENPA mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cep15 |
centrosomal protein 15 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CEP15 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
hydroquinone results in increased expression of CES1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfap44 |
cilia and flagella associated protein 44 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CFAP44 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:56,199,772...56,283,964
Ensembl chr11:56,201,049...56,283,986
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
hydroquinone results in increased expression of CFLAR mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Ch25h |
cholesterol 25-hydroxylase |
increases expression |
ISO |
hydroquinone results in increased expression of CH25H mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression decreases expression |
ISO |
hydroquinone results in increased expression of CHAC1 mRNA hydroquinone results in decreased expression of CHAC1 mRNA |
CTD |
PMID:29221148 PMID:31256213 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chp2 |
calcineurin-like EF hand protein 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CHP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:176,757,945...176,772,443
Ensembl chr 1:176,757,876...176,772,139
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
hydroquinone results in increased expression of CHST2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein] |
CTD |
PMID:23288922 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Clca4 |
chloride channel accessory 4 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CLCA4 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:233,883,851...233,903,089
|
|
G |
Cldn8 |
claudin 8 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CLDN8 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:27,875,857...27,878,106
Ensembl chr11:27,875,692...27,878,513
|
|
G |
Clic3 |
chloride intracellular channel 3 |
increases expression |
ISO |
hydroquinone results in increased expression of CLIC3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
|
|
G |
Clmp |
CXADR-like membrane protein |
increases expression |
ISO |
hydroquinone results in increased expression of CLMP mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:41,060,527...41,168,841
Ensembl chr 8:41,060,799...41,168,838
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CMPK2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cnfn |
cornifelin |
increases expression |
ISO |
hydroquinone results in increased expression of CNFN mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
|
|
G |
Cnmd |
chondromodulin |
increases response to substance increases expression multiple interactions |
ISO |
CNMD protein results in increased susceptibility to hydroquinone hydroquinone results in increased expression of CNMD mRNA Dactinomycin inhibits the reaction [hydroquinone results in increased expression of CNMD protein]; hydroquinone results in increased expression of and results in increased secretion of CNMD protein; NQO1 protein inhibits the reaction [CNMD protein results in increased susceptibility to hydroquinone]; NQO1 protein inhibits the reaction [hydroquinone results in increased expression of CNMD protein] |
CTD |
PMID:19525446 |
|
NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of COL1A1 protein [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein] |
CTD |
PMID:18055817 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
multiple interactions |
EXP |
[COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased expression of and results in increased secretion of TNF protein; [COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased secretion of IL1B protein; [COL2A1 protein co-treated with hydroquinone] results in increased expression of IL6 protein |
CTD |
PMID:29908986 PMID:29935983 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression increases expression multiple interactions |
ISO |
hydroquinone results in decreased expression of COL4A1 mRNA hydroquinone results in increased expression of COL4A1 protein [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein] |
CTD |
PMID:18055817 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
hydroquinone results in decreased expression of COL5A2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Crct1 |
cysteine-rich C-terminal 1 |
increases expression |
ISO |
hydroquinone results in increased expression of CRCT1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:178,633,789...178,635,274
Ensembl chr 2:178,634,092...178,634,394
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of CREB1 protein]; CREB1 protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; CREB1 protein affects the reaction [hydroquinone results in increased expression of TNF protein]; hydroquinone promotes the reaction [CREB1 protein binds to PPP2CA promoter] |
CTD |
PMID:23288922 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
increases expression |
ISO |
hydroquinone results in increased expression of CRISPLD2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression |
ISO |
hydroquinone results in increased expression of CRYBG2 mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
hydroquinone promotes the reaction [[CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] |
CTD |
PMID:7884313 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions decreases secretion |
ISO |
[CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK3 protein hydroquinone results in decreased secretion of CSF2 protein hydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] |
CTD |
PMID:7884313 PMID:15129224 PMID:23559866 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of CSGALNACT1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
|
|
G |
Csrnp3 |
cysteine and serine rich nuclear protein 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CSRNP3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:50,498,379...50,695,598
Ensembl chr 3:50,498,633...50,685,950
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of CSRP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Cst6 |
cystatin E/M |
increases expression |
ISO |
hydroquinone results in increased expression of CST6 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
|
|
G |
Cth |
cystathionine gamma-lyase |
increases expression |
ISO |
hydroquinone results in increased expression of CTH mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions affects localization decreases expression |
ISO |
hydroquinone inhibits the reaction [CTNNB1 protein binds to LEF1 protein]; hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein; IGF1 protein inhibits the reaction [hydroquinone results in decreased expression of CTNNB1 protein]; Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of CTNNB1 protein]; PPP2CA protein affects the reaction [hydroquinone affects the localization of CTNNB1 protein]; PPP2CA protein affects the reaction [hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; PPP2R5A protein affects the reaction [hydroquinone affects the localization of CTNNB1 protein]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] |
CTD |
PMID:28886972 PMID:30567741 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression decreases secretion |
ISO |
hydroquinone results in decreased expression of CXCL12 mRNA hydroquinone results in decreased secretion of CXCL12 protein |
CTD |
PMID:22960397 PMID:23559866 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization increases expression multiple interactions |
ISO |
hydroquinone affects the localization of CYCS protein hydroquinone results in increased expression of CYCS protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of CYCS protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYCS protein] |
CTD |
PMID:15777082 PMID:15816534 PMID:35123993 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
affects response to substance multiple interactions increases expression |
ISO |
CYP1A1 protein affects the susceptibility to hydroquinone 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of CYP1A1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYP1A1 protein] hydroquinone results in increased expression of CYP1A1 mRNA; hydroquinone results in increased expression of CYP1A1 protein |
CTD |
PMID:8242868 PMID:23416264 PMID:31256213 PMID:35123993 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
hydroquinone results in increased expression of CYP1B1 mRNA |
CTD |
PMID:23416264 PMID:31256213 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone |
CTD |
PMID:8211999 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
affects response to substance |
ISO |
CYP2B1 protein affects the susceptibility to hydroquinone |
CTD |
PMID:8242868 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
[CYP2D6 protein results in increased metabolism of bisphenol A] which results in increased chemical synthesis of hydroquinone |
CTD |
PMID:21402134 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases expression |
EXP ISO |
[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone; [CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone; [Glutathione co-treated with [CYP2E1 protein results in increased metabolism of Phenol]] results in increased chemical synthesis of [Glutathione binds to hydroquinone metabolite]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone] hydroquinone results in increased expression of CYP2E1 mRNA Resveratrol inhibits the reaction [hydroquinone results in increased expression of CYP2E1 mRNA] hydroquinone results in increased expression of CYP2E1 mRNA; hydroquinone results in increased expression of CYP2E1 protein [CYP2E1 protein affects the metabolism of Benzene] which affects the chemical synthesis of hydroquinone; PPP2CA protein affects the reaction [hydroquinone results in increased expression of CYP2E1 protein]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of CYP2E1 mRNA]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of CYP2E1 protein] |
CTD |
PMID:8211999 PMID:15051535 PMID:23202692 PMID:30567741 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of bisphenol A] which results in increased chemical synthesis of hydroquinone |
CTD |
PMID:21402134 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
[CYP3A5 protein results in increased metabolism of bisphenol A] which results in increased chemical synthesis of hydroquinone |
CTD |
PMID:21402134 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
ISO |
hydroquinone results in increased expression of CYP4F18 mRNA; hydroquinone results in increased expression of CYP4F18 protein |
CTD |
PMID:23940708 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Cysrt1 |
cysteine rich tail 1 |
increases expression |
ISO |
hydroquinone results in increased expression of CYSRT1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:8,054,195...8,057,846
Ensembl chr 3:8,053,482...8,059,721
|
|
G |
Dap |
death-associated protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of DAP mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dapl1 |
death associated protein-like 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DAPL1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:43,960,993...43,980,940
Ensembl chr 3:43,960,810...43,980,940
|
|
G |
Dapp1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides 1 |
increases expression |
ISO |
hydroquinone results in increased expression of DAPP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:226,425,890...226,475,445
Ensembl chr 2:226,425,898...226,475,423
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DBT mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
|
|
G |
Dcun1d3 |
defective in cullin neddylation 1 domain containing 3 |
increases expression |
ISO |
hydroquinone results in increased expression of DCUN1D3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:174,243,001...174,285,647
Ensembl chr 1:66,494,848...66,496,343 Ensembl chr 1:66,494,848...66,496,343
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DDAH1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of DDIT3 mRNA; hydroquinone results in increased expression of DDIT3 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; hydroquinone results in increased expression of and affects the localization of DDIT3 protein; ursodoxicoltaurine inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein]; XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein] [XBP1 protein affects the susceptibility to hydroquinone] which affects the expression of DDIT3 protein; hydroquinone promotes the reaction [XBP1 protein affects the expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 protein] |
CTD |
PMID:23416264 PMID:24053669 PMID:31256213 PMID:32334435 PMID:36646296 PMID:37148176 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
hydroquinone results in increased expression of DDIT4 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DDX60 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Depdc7 |
DEP domain containing 7 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DEPDC7 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of DEPTOR mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
decreases expression |
ISO |
hydroquinone results in decreased expression of DFFB mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
affects expression |
ISO |
hydroquinone affects the expression of DKK1 mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
increases expression |
ISO |
hydroquinone results in increased expression of DNAJA1 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
hydroquinone results in increased expression of DNAJB1 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
decreases expression |
ISO |
hydroquinone results in decreased expression of DNER mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression increases expression affects expression |
ISO |
hydroquinone results in decreased expression of DNMT1 mRNA; hydroquinone results in decreased expression of DNMT1 protein hydroquinone results in increased expression of DNMT1 mRNA hydroquinone affects the expression of DNMT1 mRNA |
CTD |
PMID:22245671 PMID:27979589 PMID:31899212 PMID:34612549 PMID:35135009 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases expression affects expression increases expression |
ISO |
hydroquinone results in decreased expression of DNMT3A mRNA; hydroquinone results in decreased expression of DNMT3A protein hydroquinone affects the expression of DNMT3A mRNA hydroquinone results in increased expression of DNMT3A mRNA |
CTD |
PMID:22245671 PMID:27979589 PMID:31899212 PMID:34612549 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
decreases expression multiple interactions affects expression |
ISO |
hydroquinone results in decreased expression of DNMT3B mRNA Decitabine affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]; trichostatin A affects the reaction [hydroquinone affects the expression of DNMT3B mRNA] |
CTD |
PMID:22245671 PMID:31899212 PMID:34612549 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dtx3l |
deltex E3 ubiquitin ligase 3L |
decreases expression |
ISO |
hydroquinone results in decreased expression of DTX3L mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:64,814,926...64,824,539
Ensembl chr11:64,814,926...64,824,538
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of DUSP1 protein |
CTD |
PMID:23290930 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp19 |
dual specificity phosphatase 19 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DUSP19 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
hydroquinone results in increased expression of DUSP5 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
hydroquinone results in increased expression of DUSP6 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dzip1 |
DAZ interacting zinc finger protein 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of DZIP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr15:95,956,329...96,009,994
Ensembl chr15:95,956,398...96,010,066
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of E2F1 mRNA; hydroquinone results in increased expression of E2F1 protein MIR7-2 promotes the reaction [hydroquinone results in increased expression of E2F1 protein] |
CTD |
PMID:33932074 PMID:37951342 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E4f1 |
E4F transcription factor 1 |
increases expression affects response to substance multiple interactions |
ISO |
hydroquinone results in increased expression of E4F1 mRNA; hydroquinone results in increased expression of E4F1 protein E4F1 protein affects the susceptibility to hydroquinone [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of H2AX protein modified form; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of RB1 protein; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of RB1 protein modified form |
CTD |
PMID:30448557 PMID:30506647 |
|
NCBI chr10:13,471,478...13,495,018
Ensembl chr10:13,474,456...13,485,974
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
increases expression |
ISO |
hydroquinone results in increased expression of ECM2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Edn1 |
endothelin 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of EDN1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Edn2 |
endothelin 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of EDN2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
decreases expression |
ISO |
hydroquinone results in decreased expression of EEF2K mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Efna1 |
ephrin A1 |
multiple interactions |
ISO |
[hydroquinone co-treated with Hemin] affects the expression of EFNA1 mRNA |
CTD |
PMID:32198055 |
|
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Egr3 |
early growth response 3 |
increases expression |
ISO |
hydroquinone results in increased expression of EGR3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of EHMT2 protein |
CTD |
PMID:27979589 |
|
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Eid3 |
EP300 interacting inhibitor of differentiation 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of EID3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:20,860,073...20,861,395
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation increases expression multiple interactions |
ISO |
hydroquinone results in increased phosphorylation of EIF2AK3 protein hydroquinone results in increased expression of EIF2AK3 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of EIF2AK3 protein] |
CTD |
PMID:24053669 PMID:36646296 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation |
ISO |
XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:24053669 PMID:37148176 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
ISO |
hydroquinone results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elavl1 |
ELAV like RNA binding protein 1 |
multiple interactions increases degradation decreases expression |
ISO |
ELAVL1 protein inhibits the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; ELAVL1 protein inhibits the reaction [hydroquinone results in decreased expression of SIRT3 protein]; ELAVL1 protein inhibits the reaction [hydroquinone results in increased degradation of SIRT3 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 protein]; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 mRNA] hydroquinone results in increased degradation of ELAVL1 mRNA hydroquinone results in decreased expression of ELAVL1 mRNA; hydroquinone results in decreased expression of ELAVL1 protein |
CTD |
PMID:35302183 |
|
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
|
|
G |
Elavl2 |
ELAV like RNA binding protein 2 |
multiple interactions |
ISO |
[[NOX4 protein results in decreased expression of ELAVL2 protein] which promotes the reaction SIDT2 protein] promotes the reaction [hydroquinone results in decreased degradation of SIRT3 protein] |
CTD |
PMID:35302183 |
|
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
increases expression |
ISO |
hydroquinone results in increased expression of ELF3 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Elf5 |
E74 like ETS transcription factor 5 |
increases expression |
ISO |
hydroquinone results in increased expression of ELF5 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:89,808,837...89,836,977
Ensembl chr 3:89,797,880...89,836,973
|
|
G |
Elmod1 |
ELMO domain containing 1 |
increases expression |
ISO |
hydroquinone results in increased expression of ELMOD1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
|
|
G |
Elovl4 |
ELOVL fatty acid elongase 4 |
increases expression |
ISO |
hydroquinone results in increased expression of ELOVL4 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:84,702,916...84,729,466
Ensembl chr 8:84,702,362...84,729,697
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ELOVL5 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Elp2 |
elongator acetyltransferase complex subunit 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ELP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr18:15,885,940...15,921,564
Ensembl chr18:15,885,934...15,921,599
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
increases expression |
ISO |
hydroquinone results in increased expression of EPB41L3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
multiple interactions |
EXP |
EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone] |
CTD |
PMID:8211999 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Eps8l1 |
EPS8-like 1 |
increases expression |
ISO |
hydroquinone results in increased expression of EPS8L1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:69,343,202...69,359,778
Ensembl chr 1:69,344,243...69,363,524
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ERBB2 mRNA |
CTD |
PMID:22245671 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
hydroquinone results in increased expression of EREG mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Erich5 |
glutamate-rich 5 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ERICH5 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:65,655,829...65,682,221
Ensembl chr 7:65,657,204...65,680,207
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ERN1 protein] |
CTD |
PMID:36646296 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ESR1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Etv4 |
ETS variant transcription factor 4 |
increases expression |
ISO |
hydroquinone results in increased expression of ETV4 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
|
|
G |
Exosc3 |
exosome component 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of EXOSC3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:59,573,849...59,579,065
Ensembl chr 5:59,573,886...59,579,060
|
|
G |
Exosc6 |
exosome component 6 |
increases expression |
ISO |
hydroquinone results in increased expression of EXOSC6 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:39,022,171...39,023,585
Ensembl chr19:39,022,183...39,023,515
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
decreases expression |
ISO |
hydroquinone results in decreased expression of EZH2 protein |
CTD |
PMID:27979589 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
ISO |
hydroquinone results in decreased expression of F2R mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
[KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of FABP4 mRNA |
CTD |
PMID:37245849 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression multiple interactions |
ISO |
hydroquinone results in decreased expression of FADD mRNA FADD protein affects the reaction [hydroquinone results in increased cleavage of BID protein]; FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein]; FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein] |
CTD |
PMID:15452088 PMID:23288922 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fahd2a |
fumarylacetoacetate hydrolase domain containing 2A |
decreases expression |
ISO |
hydroquinone results in decreased expression of FAHD2A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:114,657,176...114,665,349
Ensembl chr 3:114,655,865...114,665,356
|
|
G |
Fam117b |
family with sequence similarity 117, member B |
decreases expression |
ISO |
hydroquinone results in decreased expression of FAM117B mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:61,340,284...61,418,531
Ensembl chr 9:61,340,249...61,408,483
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
decreases expression |
ISO |
hydroquinone results in decreased expression of FAM13A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
increases expression |
ISO |
hydroquinone results in increased expression of FAM43A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
decreases expression |
ISO |
hydroquinone results in decreased expression of FAM83D mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of FAS protein [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of FAS protein |
CTD |
PMID:23776099 PMID:28444915 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
hydroquinone results in increased expression of FASLG protein |
CTD |
PMID:23776099 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fau |
FAU ubiquitin like and ribosomal protein S30 fusion |
multiple interactions |
ISO |
FAU protein affects the reaction [hydroquinone results in increased expression of and results in increased activity of NQO1 protein]; FAU protein affects the reaction [hydroquinone results in increased expression of H2AX protein] |
CTD |
PMID:22687461 |
|
NCBI chr 1:203,350,226...203,351,741
Ensembl chr 1:203,350,189...203,351,742 Ensembl chr 1:203,350,189...203,351,742 Ensembl chr 6:203,350,189...203,351,742
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
hydroquinone results in decreased expression of FBXO5 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of FGFR3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression |
ISO |
hydroquinone results in increased expression of FIBIN mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Flg |
filaggrin |
increases expression |
ISO |
hydroquinone results in increased expression of FLG mRNA; hydroquinone results in increased expression of FLG protein |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Flg2 |
filaggrin 2 |
increases expression |
ISO |
hydroquinone results in increased expression of FLG2 mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,789,792...178,802,232
|
|
G |
Fn1 |
fibronectin 1 |
affects expression |
ISO |
hydroquinone affects the expression of FN1 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression increases phosphorylation multiple interactions |
ISO |
hydroquinone results in decreased expression of FOS mRNA hydroquinone results in increased phosphorylation of FOS protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of FOS protein]; FOS protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; hydroquinone promotes the reaction [FOS protein binds to MIR122 promoter] |
CTD |
PMID:15452088 PMID:23791922 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
hydroquinone results in increased expression of FOSL1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fry |
FRY microtubule binding protein |
increases expression |
ISO |
hydroquinone results in increased expression of FRY mRNA |
CTD |
PMID:31256213 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Fsip1 |
fibrous sheath interacting protein 1 |
increases expression |
ISO |
hydroquinone results in increased expression of FSIP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:105,074,584...105,217,180
Ensembl chr 3:105,068,543...105,217,167
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
hydroquinone results in increased expression of FTH1 mRNA; hydroquinone results in increased expression of FTH1 protein |
CTD |
PMID:15452088 PMID:23738040 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fut1 |
fucosyltransferase 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of FUT1 mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
|
|
G |
Fzd2 |
frizzled class receptor 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of FZD2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression |
ISO |
hydroquinone results in increased expression of G0S2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
hydroquinone results in increased expression of GADD45A mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gas1 |
growth arrest-specific 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of GAS1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:4,482,168...4,485,153
|
|
G |
Gask1b |
golgi associated kinase 1B |
decreases expression |
ISO |
hydroquinone results in decreased expression of GASK1B mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
|
|
G |
Gata1 |
GATA binding protein 1 |
decreases expression multiple interactions |
ISO |
hydroquinone results in decreased expression of GATA1 mRNA Decitabine inhibits the reaction [hydroquinone inhibits the reaction [Hemin results in increased expression of GATA1 mRNA]]; hydroquinone inhibits the reaction [GATA1 protein binds to HBA1 gene]; hydroquinone inhibits the reaction [GATA1 protein binds to HBD gene]; hydroquinone inhibits the reaction [GATA1 protein binds to HBG1 gene]; hydroquinone inhibits the reaction [Hemin results in increased expression of GATA1 mRNA] |
CTD |
PMID:21414390 PMID:23973255 PMID:37329354 |
|
NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530
|
|
G |
Gata2 |
GATA binding protein 2 |
multiple interactions decreases expression |
ISO |
hydroquinone affects the reaction [Hemin affects the expression of GATA2 mRNA]; hydroquinone inhibits the reaction [Hemin results in decreased expression of GATA2 protein]; hydroquinone promotes the reaction [GATA2 protein binds to HBB gene]; hydroquinone promotes the reaction [GATA2 protein binds to HBG2 gene]; hydroquinone promotes the reaction [GATA2 protein binds to HBM gene]; hydroquinone promotes the reaction [GATA2 protein binds to HBP1 gene]; hydroquinone promotes the reaction [Hemin results in decreased expression of GATA2 mRNA] hydroquinone results in decreased expression of GATA2 mRNA |
CTD |
PMID:21414390 PMID:37329354 |
|
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of GBP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions affects methylation |
ISO |
hydroquinone results in increased expression of GCLC mRNA; hydroquinone results in increased expression of GCLC protein [hydroquinone affects the methylation of GCLC promoter] which results in decreased abundance of 5-Methylcytosine; [hydroquinone affects the methylation of GCLC promoter] which results in increased abundance of 5-hydroxymethylcytosine; Resveratrol promotes the reaction [hydroquinone results in increased expression of GCLC mRNA]; TET1 protein affects the reaction [hydroquinone results in increased expression of GCLC mRNA] |
CTD |
PMID:23290930 PMID:23940045 PMID:30547568 PMID:32334435 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
hydroquinone results in increased expression of GCLM mRNA; hydroquinone results in increased expression of GCLM protein |
CTD |
PMID:21059386 PMID:30547568 PMID:31256213 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gda |
guanine deaminase |
increases expression |
ISO |
hydroquinone results in increased expression of GDA mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
hydroquinone results in increased expression of GDF15 mRNA |
CTD |
PMID:23416264 PMID:31256213 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
increases expression |
ISO |
hydroquinone results in increased expression of GDPD3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of GFPT1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
|
|
G |
Gk |
glycerol kinase |
increases expression |
ISO |
hydroquinone results in increased expression of GK mRNA |
CTD |
PMID:31256213 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glmp |
glycosylated lysosomal membrane protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of GLMP mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
|
|
G |
Glrx |
glutaredoxin |
increases expression |
ISO |
hydroquinone results in increased expression of GLRX mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
ISO |
hydroquinone results in decreased expression of GLUL mRNA |
CTD |
PMID:31256213 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gmpr |
guanosine monophosphate reductase |
decreases expression |
ISO |
hydroquinone results in decreased expression of GMPR mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:19,151,820...19,189,626
Ensembl chr17:19,151,815...19,189,621
|
|
G |
Gosr2 |
golgi SNAP receptor complex member 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of GOSR2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of GOT1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
hydroquinone results in increased expression of GPAT3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpr155 |
G protein-coupled receptor 155 |
decreases expression |
ISO |
hydroquinone results in decreased expression of GPR155 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:58,216,422...58,270,350
Ensembl chr 3:58,216,423...58,270,275
|
|
G |
Gpr15lg |
G protein-coupled receptor 15 ligand |
decreases expression |
ISO |
hydroquinone results in decreased expression of GPR15LG mRNA |
CTD |
PMID:31256213 |
|
NCBI chr16:12,868,270...12,875,876
Ensembl chr16:12,868,270...12,875,876
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
decreases expression |
ISO |
hydroquinone results in decreased expression of GPRC5A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
hydroquinone results in increased expression of GPX2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
increases expression |
ISO |
hydroquinone results in increased expression of GRB10 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
affects expression |
ISO |
hydroquinone affects the expression of GRB2 protein |
CTD |
PMID:20021034 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Grhl1 |
grainyhead-like transcription factor 1 |
increases expression |
ISO |
hydroquinone results in increased expression of GRHL1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
|
|
G |
Gsdmd |
gasdermin D |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of GSDMD protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of GSDMD protein] |
CTD |
PMID:36646296 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
hydroquinone results in increased expression of and results in decreased phosphorylation of and results in increased activity of GSK3B protein; IGF1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of GSK3B protein]; Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of GSK3B protein] |
CTD |
PMID:28886972 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Peroxynitrous Acid results in decreased activity of GSR protein] |
CTD |
PMID:15831208 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of GSS protein NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of GSS protein] |
CTD |
PMID:21059386 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects response to substance |
ISO |
GSTM1 affects the susceptibility to hydroquinone; GSTM1 gene polymorphism affects the susceptibility to hydroquinone |
CTD |
PMID:15141365 PMID:19778234 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
affects response to substance |
ISO |
GSTP1 affects the susceptibility to hydroquinone |
CTD |
PMID:19778234 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression affects response to substance |
ISO |
hydroquinone results in increased expression of GSTT1 mRNA GSTT1 affects the susceptibility to hydroquinone |
CTD |
PMID:19778234 PMID:23290930 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtpbp2 |
GTP binding protein 2 |
increases expression |
ISO |
hydroquinone results in increased expression of GTPBP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
increases expression |
ISO |
hydroquinone results in increased expression of GUCY1B1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
Gvin1 |
GTPase, very large interferon inducible 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of GVINP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:160,279,767...160,306,701
Ensembl chr 1:160,277,126...160,306,331
|
|
G |
Gypa |
glycophorin A |
decreases expression |
ISO |
hydroquinone results in decreased expression of GYPA protein |
CTD |
PMID:21414390 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
hydroquinone results in decreased expression of H1-4 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
H1f5 |
H1.5 linker histone, cluster member |
decreases expression |
ISO |
hydroquinone results in decreased expression of H1-5 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160
|
|
G |
H2ac12 |
H2A clustered histone 12 |
decreases expression |
ISO |
hydroquinone results in decreased expression of H2AC12 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr17:42,486,415...42,486,880
Ensembl chr17:42,486,415...42,486,941
|
|
G |
H2ac18 |
H2A clustered histone 18 |
decreases expression |
ISO |
hydroquinone results in decreased expression of H2AC18 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 2:183,808,398...183,808,992
|
|
G |
H2ac20 |
H2A clustered histone 20 |
decreases expression |
ISO |
hydroquinone results in decreased expression of H2AC20 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 2:183,779,879...183,780,357
|
|
G |
H2ac21 |
H2A clustered histone 21 |
decreases expression |
ISO |
hydroquinone results in decreased expression of H2AC21 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 2:183,779,355...183,779,788
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases expression increases phosphorylation affects localization |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; [ABT-737 co-treated with hydroquinone] results in increased expression of H2AX protein; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of H2AX protein modified form; [SIRT1 protein affects the susceptibility to hydroquinone] which affects the expression of H2AX protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of H2AX protein]; POLH protein affects the reaction [hydroquinone results in increased expression of H2AX protein]; WRN gene mutant form promotes the reaction [hydroquinone results in increased expression of H2AX protein alternative form]; WRN protein affects the reaction [hydroquinone results in increased expression of H2AX protein] FAU protein affects the reaction [hydroquinone results in increased expression of H2AX protein] hydroquinone results in increased phosphorylation of H2AX protein hydroquinone affects the localization of H2AX protein modified form hydroquinone results in increased expression of H2AX protein; hydroquinone results in increased expression of H2AX protein alternative form |
CTD |
PMID:17875398 PMID:18835433 PMID:20036648 PMID:21267443 PMID:22687461 PMID:22981619 PMID:23940708 PMID:26335980 PMID:26822515 PMID:27515134 PMID:28843007 PMID:30506647 PMID:35123993 More...
|
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
H4c14 |
H4 clustered histone 14 |
decreases expression |
ISO |
hydroquinone results in decreased expression of H4C2 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 2:183,831,601...183,831,996
Ensembl chr 2:183,825,994...183,832,048
|
|
G |
H4cl1 |
histone H4C like 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of H4C6 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr17:41,368,743...41,426,735
|
|
G |
H4f3 |
H1.3 linker histone, cluster member |
decreases expression |
ISO |
hydroquinone results in decreased expression of H1-3 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [GATA1 protein binds to HBA1 gene] |
CTD |
PMID:37329354 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hbb |
hemoglobin subunit beta |
multiple interactions decreases methylation |
ISO |
Decitabine inhibits the reaction [hydroquinone inhibits the reaction [Hemin results in increased expression of HBB mRNA]]; hydroquinone inhibits the reaction [Hemin results in increased expression of HBB mRNA]; hydroquinone promotes the reaction [GATA2 protein binds to HBB gene] hydroquinone results in decreased methylation of HBB promoter |
CTD |
PMID:21414390 PMID:23973255 PMID:37329354 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hbb-b1 |
hemoglobin, beta adult major chain |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [GATA1 protein binds to HBD gene] |
CTD |
PMID:37329354 |
|
NCBI chr 1:158,224,175...158,231,675
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
hydroquinone results in increased expression of HBEGF mRNA |
CTD |
PMID:31256213 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hbg1 |
hemoglobin subunit gamma 1 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [GATA1 protein binds to HBG1 gene] |
CTD |
PMID:37329354 |
|
NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:158,271,873...158,273,425
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
multiple interactions |
ISO |
hydroquinone promotes the reaction [GATA2 protein binds to HBP1 gene] |
CTD |
PMID:37329354 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hdac1 |
histone deacetylase 1 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of HDAC1 mRNA; hydroquinone results in increased expression of HDAC1 protein trichostatin A inhibits the reaction [hydroquinone results in increased expression of HDAC1 mRNA] |
CTD |
PMID:27220438 PMID:30448557 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac2 |
histone deacetylase 2 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of HDAC2 mRNA; hydroquinone results in increased expression of HDAC2 protein trichostatin A inhibits the reaction [hydroquinone results in increased expression of HDAC2 mRNA] |
CTD |
PMID:27220438 PMID:30448557 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdac9 |
histone deacetylase 9 |
increases expression |
ISO |
hydroquinone results in increased expression of HDAC9 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Hfe |
homeostatic iron regulator |
decreases expression |
ISO |
hydroquinone results in decreased expression of HFE mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
|
|
G |
Hist1h4m |
histone cluster 1, H4m |
decreases expression |
ISO |
hydroquinone results in decreased expression of H4C1 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
|
|
G |
Hjurp |
Holliday junction recognition protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of HJURP mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
multiple interactions |
ISO |
decitabine inhibits the reaction [hydroquinone inhibits the reaction [Hemin results in increased expression of HMBS mRNA]]; hydroquinone inhibits the reaction [Hemin results in increased expression of HMBS mRNA] |
CTD |
PMID:21414390 PMID:23973255 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of HMGB2 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of HMOX1 mRNA; hydroquinone results in increased expression of HMOX1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; AG 1879 inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; bisindolylmaleimide I inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Cysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Dithiothreitol inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Staurosporine inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Staurosporine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Wortmannin inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Wortmannin inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; [Resveratrol co-treated with hydroquinone] results in increased expression of HMOX1 protein; ferric chloride promotes the reaction [hydroquinone results in increased expression of HMOX1 protein]; NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein]; Resveratrol promotes the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; risuteganib promotes the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; risuteganib promotes the reaction [hydroquinone results in increased expression of HMOX1 protein]; S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein] |
CTD |
PMID:17464197 PMID:21059386 PMID:23290930 PMID:28645578 PMID:29508652 PMID:30547568 PMID:31256213 PMID:32141582 PMID:32334435 PMID:32818234 PMID:36646296 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hotairm1 |
Hoxa transcript antisense RNA, myeloid-specific 1 |
multiple interactions affects expression affects methylation |
ISO |
Decitabine affects the reaction [hydroquinone affects the expression of HOTAIRM1 mRNA]; Decitabine affects the reaction [hydroquinone affects the methylation of HOTAIRM1 promoter]; trichostatin A affects the reaction [hydroquinone affects the expression of HOTAIRM1 mRNA]; trichostatin A affects the reaction [hydroquinone affects the methylation of HOTAIRM1 promoter] |
CTD |
PMID:31899212 |
|
NCBI chr 4:81,258,793...81,262,291
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions affects expression |
ISO |
3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of HRAS protein]; Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of HRAS protein]; hydroquinone promotes the reaction [PARP1 protein binds to and results in increased ADP-ribosylation of and results in increased expression of HRAS protein]; PARP1 protein promotes the reaction [hydroquinone results in increased expression of HRAS protein] hydroquinone affects the expression of HRAS mRNA; hydroquinone affects the expression of HRAS protein |
CTD |
PMID:26047893 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
increases expression |
ISO |
hydroquinone results in increased expression of HSD17B2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
increases expression |
ISO |
hydroquinone results in increased expression of HSPA13 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO |
hydroquinone results in increased expression of HSPA2 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of HSPA5 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein] |
CTD |
PMID:24053669 PMID:36646296 PMID:37148176 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
decreases expression |
ISO |
hydroquinone results in decreased expression of HTR1A protein |
CTD |
PMID:27606422 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
decreases expression |
ISO |
hydroquinone results in decreased expression of HTR1B protein |
CTD |
PMID:27606422 |
|
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
|
|
G |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
decreases expression |
ISO |
hydroquinone results in decreased expression of HYLS1 mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression |
ISO |
hydroquinone results in increased expression of ID1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of ID3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
increases expression |
ISO |
hydroquinone results in increased expression of ID4 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
ISO |
hydroquinone results in increased expression of IER3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi44 |
interferon-induced protein 44 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IFI44 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
decreases expression |
ISO |
hydroquinone results in decreased expression of IFI44L mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IFIH1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IFIT3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IFITM1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein]; hydroquinone inhibits the reaction [Amino Acids, Peptides, and Proteins results in increased expression of IFNG protein]; IFNG protein promotes the reaction [[Lipopolysaccharides co-treated with hydroquinone] results in increased abundance of Nitric Oxide] |
CTD |
PMID:3137358 PMID:7884313 PMID:22465845 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
ISO |
hydroquinone results in increased expression of IFRD1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
IGF1 protein inhibits the reaction [hydroquinone results in decreased expression of CTNNB1 protein]; IGF1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of GSK3B protein]; IGF1 protein inhibits the reaction [hydroquinone results in increased expression of CASP3 protein modified form] |
CTD |
PMID:28886972 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IGFBP3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:20054000 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases secretion |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA] hydroquinone results in increased secretion of IL10 protein hydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] |
CTD |
PMID:17464197 PMID:17572062 PMID:23559866 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
multiple interactions increases expression |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA] hydroquinone results in increased expression of IL12B mRNA |
CTD |
PMID:15894107 PMID:17464197 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il15 |
interleukin 15 |
decreases secretion |
ISO |
hydroquinone results in decreased secretion of IL15 protein |
CTD |
PMID:23559866 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il17a |
interleukin 17A |
increases secretion |
EXP |
hydroquinone results in increased secretion of IL17A protein |
CTD |
PMID:29935983 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
multiple interactions increases secretion |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased secretion of IL18 protein] |
CTD |
PMID:36646296 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions increases expression decreases cleavage |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased cleavage of IL1A protein] Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of IL1A protein]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]]; PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein] hydroquinone results in increased expression of IL1A mRNA; hydroquinone results in increased expression of IL1A protein hydroquinone results in decreased cleavage of IL1A protein |
CTD |
PMID:1868253 PMID:8548860 PMID:9118901 PMID:28836394 PMID:31256213 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
decreases cleavage multiple interactions increases expression decreases secretion |
ISO EXP |
hydroquinone results in decreased cleavage of IL1B protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; hydroquinone results in increased expression of and results in increased secretion of IL1B protein hydroquinone results in increased expression of IL1B mRNA hydroquinone results in decreased secretion of IL1B protein [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of IL1B mRNA; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] [COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased secretion of IL1B protein; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] |
CTD |
PMID:8548860 PMID:9118901 PMID:17464197 PMID:19148301 PMID:22717997 PMID:29908986 PMID:31256213 PMID:36646296 PMID:37245849 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1f10 |
interleukin 1 family member 10 |
increases expression |
ISO |
hydroquinone results in increased expression of IL1F10 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:7,072,511...7,075,439
Ensembl chr 3:7,072,511...7,075,439
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
increases secretion |
ISO |
hydroquinone results in increased secretion of IL1RN protein |
CTD |
PMID:23559866 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 protein] |
CTD |
PMID:9571986 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il23a |
interleukin 23 subunit alpha |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL23A mRNA] |
CTD |
PMID:17464197 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il33 |
interleukin 33 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IL33 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il36g |
interleukin 36, gamma |
increases expression |
ISO |
hydroquinone results in increased expression of IL36G mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
increases expression |
ISO |
hydroquinone results in increased expression of IL36RN mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
hydroquinone promotes the reaction [keyhole-limpet hemocyanin results in increased expression of IL4 mRNA]; hydroquinone promotes the reaction [keyhole-limpet hemocyanin results in increased expression of IL4 protein] |
CTD |
PMID:12153512 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases secretion |
EXP ISO |
[COL2A1 protein co-treated with hydroquinone] results in increased expression of IL6 protein; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] [hydroquinone co-treated with TNF protein] results in increased secretion of IL6 protein hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] hydroquinone results in decreased secretion of IL6 protein |
CTD |
PMID:17464197 PMID:19148301 PMID:20054000 PMID:22302391 PMID:22717997 PMID:23559866 PMID:29935983 PMID:34200499 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhba |
inhibin subunit beta A |
increases expression |
ISO |
hydroquinone results in increased expression of INHBA mRNA |
CTD |
PMID:31256213 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Inhbe |
inhibin subunit beta E |
decreases expression |
ISO |
hydroquinone results in decreased expression of INHBE mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
increases expression |
ISO |
hydroquinone results in increased expression of INPP4B mRNA |
CTD |
PMID:31256213 |
|
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IRAK1 mRNA |
CTD |
PMID:30090394 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
hydroquinone inhibits the reaction [AKT1 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [AKT2 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [AKT3 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [TICAM1 protein results in increased phosphorylation of IRF3 protein] |
CTD |
PMID:28883758 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Irs1 |
insulin receptor substrate 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of IRS1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
decreases expression |
ISO |
hydroquinone results in decreased expression of ISG15 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases activity decreases expression |
ISO |
hydroquinone results in decreased activity of ITGB1 protein hydroquinone results in decreased expression of ITGB1 mRNA hydroquinone results in decreased expression of ITGB1 protein |
CTD |
PMID:17464197 PMID:19148301 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb2 |
integrin subunit beta 2 |
decreases expression increases expression |
ISO |
hydroquinone results in decreased expression of ITGB2 protein hydroquinone results in decreased expression of ITGB2 mRNA hydroquinone results in increased expression of ITGB2 protein |
CTD |
PMID:17464197 PMID:19148301 PMID:21664406 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itgb3 |
integrin subunit beta 3 |
increases expression |
ISO |
hydroquinone results in increased expression of ITGB3 protein |
CTD |
PMID:21664406 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Ivl |
involucrin |
increases expression |
ISO |
hydroquinone results in increased expression of IVL mRNA; hydroquinone results in increased expression of IVL protein |
CTD |
PMID:25240866 PMID:31256213 |
|
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of JAG1 mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jchain |
joining chain of multimeric IgA and IgM |
decreases expression |
ISO |
hydroquinone results in decreased expression of JCHAIN mRNA |
CTD |
PMID:29221148 |
|
NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
|
|
G |
Jrk |
Jrk helix-turn-helix protein |
decreases expression |
ISO |
hydroquinone results in decreased expression of JRK mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:106,590,662...106,595,345
Ensembl chr 7:106,589,484...106,596,371
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects localization multiple interactions increases phosphorylation |
ISO |
hydroquinone affects the localization of JUN protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of JUN protein]; hydroquinone promotes the reaction [JUN protein binds to MIR122 promoter]; hydroquinone promotes the reaction [JUN protein binds to PPP2CA promoter]; JUN protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; JUN protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; JUN protein affects the reaction [hydroquinone results in increased expression of TNF protein]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased phosphorylation of JUN protein] |
CTD |
PMID:23288922 PMID:23791922 PMID:26807887 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kbtbd6 |
kelch repeat and BTB domain containing 6 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KBTBD6 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr15:54,848,285...54,850,042
Ensembl chr15:54,848,446...54,850,453
|
|
G |
Kbtbd7 |
kelch repeat and BTB domain containing 7 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KBTBD7 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr15:54,806,878...54,811,457
Ensembl chr15:54,806,873...54,811,687
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KCNJ15 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
|
|
G |
Kdm6a |
lysine demethylase 6A |
decreases expression |
ISO |
hydroquinone results in decreased expression of KDM6A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KEAP1 protein |
CTD |
PMID:23290930 PMID:36646296 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kics2 |
KICSTOR subunit 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KICS2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:57,284,213...57,299,070
Ensembl chr 7:57,284,192...57,297,486
|
|
G |
Kif18a |
kinesin family member 18A |
decreases expression |
ISO |
hydroquinone results in decreased expression of KIF18A mRNA |
CTD |
PMID:23416264 |
|
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
|
|
G |
Kitlg |
KIT ligand |
increases expression |
ISO |
hydroquinone results in increased expression of KITLG mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf2 |
KLF transcription factor 2 |
increases expression |
ISO |
hydroquinone results in increased expression of KLF2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
ISO |
[KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of KLF4 mRNA |
CTD |
PMID:37245849 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klf7 |
KLF transcription factor 7 |
increases expression |
ISO |
hydroquinone results in increased expression of KLF7 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
|
|
G |
Klhl31 |
kelch-like family member 31 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KLHL31 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 8:78,515,514...78,538,873
Ensembl chr 8:78,515,514...78,538,873
|
|
G |
Klk6 |
kallikrein related-peptidase 6 |
increases expression |
ISO |
hydroquinone results in increased expression of KLK6 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
|
|
G |
Klrg2 |
killer cell lectin like receptor G2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KLRG2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 4:67,360,216...67,374,867
Ensembl chr 4:67,363,919...67,374,147
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
decreases response to substance multiple interactions |
ISO |
KMT2A mutant form results in decreased susceptibility to hydroquinone [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of APP mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of FABP4 mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of IL1B mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of KLF4 mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of LPL mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of PPARG mRNA |
CTD |
PMID:37245849 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions increases expression affects expression |
ISO |
[PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of KRAS protein hydroquinone results in increased expression of KRAS protein hydroquinone affects the expression of KRAS mRNA |
CTD |
PMID:27515134 PMID:28444915 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt13 |
keratin 13 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KRT13 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:85,051,887...85,056,099
Ensembl chr10:85,051,889...85,056,084
|
|
G |
Krt19 |
keratin 19 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KRT19 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt23 |
keratin 23 |
increases expression |
ISO |
hydroquinone results in increased expression of KRT23 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
|
|
G |
Krt24 |
keratin 24 |
decreases expression |
ISO |
hydroquinone results in decreased expression of KRT24 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr10:84,232,163...84,237,299
Ensembl chr10:84,232,164...84,237,299
|
|
G |
Krt78 |
keratin 78 |
increases expression |
ISO |
hydroquinone results in increased expression of KRT78 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:133,074,193...133,081,536
Ensembl chr 7:133,074,215...133,082,021
|
|
G |
Krt80 |
keratin 80 |
increases expression |
ISO |
hydroquinone results in increased expression of KRT80 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
|
|
G |
Lama4 |
laminin subunit alpha 4 |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of LAMA4 protein [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein] |
CTD |
PMID:18055817 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Lasp1 |
LIM and SH3 protein 1 |
affects expression |
ISO |
hydroquinone affects the expression of LASP1 protein |
CTD |
PMID:20021034 |
|
NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
ISO |
hydroquinone results in increased expression of LCN2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions decreases expression |
ISO |
hydroquinone inhibits the reaction [CTNNB1 protein binds to LEF1 protein] hydroquinone results in decreased expression of LEF1 protein |
CTD |
PMID:28886972 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lemd1 |
LEM domain containing 1 |
decreases expression |
ISO |
hydroquinone results in decreased expression of LEMD1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr13:43,631,705...43,697,765
Ensembl chr13:43,665,926...43,697,948
|
|
G |
Lgals9 |
galectin 9 |
increases expression |
ISO |
hydroquinone results in increased expression of LGALS9 mRNA |
CTD |
PMID:29221148 |
|
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
|
|
G |
Lgalsl |
galectin-like |
increases expression |
ISO |
hydroquinone results in increased expression of LGALSL mRNA |
CTD |
PMID:31256213 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
decreases expression |
ISO |
hydroquinone results in decreased expression of LGR4 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
|
|
G |
Lipg |
lipase G, endothelial type |
increases expression |
ISO |
hydroquinone results in increased expression of LIPG mRNA |
CTD |
PMID:31256213 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lmna |
lamin A/C |
affects expression |
ISO |
hydroquinone affects the expression of LMNA protein |
CTD |
PMID:17181942 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Loricrin |
loricrin cornified envelope precursor protein |
increases expression |
ISO |
hydroquinone results in increased expression of LORICRIN mRNA hydroquinone results in increased expression of LORICRIN protein |
CTD |
PMID:25240866 PMID:31256213 |
|
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
ISO |
[KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of LPL mRNA |
CTD |
PMID:37245849 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lrrc27 |
leucine rich repeat containing 27 |
decreases expression |
ISO |
hydroquinone results in decreased expression of LRRC27 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:194,004,967...194,035,087
Ensembl chr 1:194,005,182...194,035,084
|
|
G |
Lrrc71 |
leucine rich repeat containing 71 |
increases expression |
ISO |
hydroquinone results in increased expression of LRRC71 mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 2:173,194,792...173,207,448
Ensembl chr 2:173,194,792...173,207,448
|
|
G |
Lrriq3 |
leucine-rich repeats and IQ motif containing 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of LRRIQ3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:244,119,975...244,214,590
Ensembl chr 2:244,126,200...244,212,339
|
|
G |
Lss |
lanosterol synthase |
decreases expression |
ISO |
hydroquinone results in decreased expression of LSS mRNA |
CTD |
PMID:31256213 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
decreases expression |
ISO |
hydroquinone results in decreased expression of LY6E mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Ly96 |
lymphocyte antigen 96 |
increases expression |
ISO |
hydroquinone results in increased expression of LY96 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
|
|
G |
Lypd5 |
Ly6/Plaur domain containing 5 |
increases expression |
ISO |
hydroquinone results in increased expression of LYPD5 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:79,929,818...79,941,791
Ensembl chr 1:79,935,240...79,941,039
|
|
G |
Macroh2a1 |
macroH2A.1 histone |
decreases expression |
ISO |
hydroquinone results in decreased expression of MACROH2A1 protein |
CTD |
PMID:35698848 |
|
NCBI chr17:8,479,331...8,542,071
Ensembl chr17:8,479,372...8,542,072
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
hydroquinone results in increased expression of MAFF mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
multiple interactions |
ISO |
[hydroquinone co-treated with Hemin] affects the expression of MAGI1 mRNA; [hydroquinone co-treated with Hemin] affects the expression of MAGI1 protein; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A protein]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RASSF5 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RASSF5 protein] |
CTD |
PMID:32198055 |
|
NCBI chr 4:126,205,663...126,811,354
Ensembl chr 4:126,206,816...126,811,691
|
|
G |
Map1b |
microtubule-associated protein 1B |
increases expression |
ISO |
hydroquinone results in increased expression of MAP1B mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein]; hydroquinone affects the localization of and results in increased degradation of MAP1LC3A protein |
CTD |
PMID:35302183 |
|
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases lipidation multiple interactions |
ISO |
hydroquinone results in increased lipidation of MAP1LC3B protein 4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; ATF6 protein affects the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:37148176 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK3 protein]; MAP2K1 protein inhibits the reaction [hydroquinone results in increased expression of PPP2CA protein] |
CTD |
PMID:23288922 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map7d2 |
MAP7 domain containing 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of MAP7D2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr X:35,372,453...35,488,073
Ensembl chr X:35,372,700...35,488,091
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein]; [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in decreased phosphorylation of MAPK1 protein; hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein; MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein] hydroquinone results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:15129224 PMID:23288922 PMID:23290930 PMID:23791922 PMID:35561756 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases phosphorylation |
ISO |
Chloroquine inhibits the reaction [hydroquinone results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:35302183 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK3 protein]; [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK3 protein; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in decreased phosphorylation of MAPK3 protein; hydroquinone results in increased phosphorylation of and results in increased activity of MAPK3 protein; MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK3 protein] hydroquinone results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:15129224 PMID:23288922 PMID:23290930 PMID:23791922 PMID:35561756 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
hydroquinone results in increased phosphorylation of MAPK8 protein hydroquinone results in decreased expression of and results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:23791922 PMID:37148176 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Marchf3 |
membrane associated ring-CH-type finger 3 |
increases expression |
ISO |
hydroquinone results in increased expression of MARCHF3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150
|
|
G |
Mbd2 |
methyl-CpG binding domain protein 2 |
decreases expression multiple interactions increases expression |
ISO |
hydroquinone results in decreased expression of MBD2 mRNA PARP1 protein affects the reaction [hydroquinone results in increased expression of MBD2 protein] |
CTD |
PMID:22245671 PMID:30448557 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
|
|
G |
Mbnl3 |
muscleblind-like splicing regulator 3 |
decreases expression |
ISO |
hydroquinone results in decreased expression of MBNL3 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr X:130,641,942...130,737,179
Ensembl chr X:130,648,538...130,737,056
|
|
G |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
increases expression |
ISO |
hydroquinone results in increased expression of MBOAT2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 6:41,471,135...41,597,599
Ensembl chr 6:41,471,161...41,593,485
|
|
G |
Mc1r |
melanocortin 1 receptor |
decreases expression |
ISO |
hydroquinone results in decreased expression of MC1R mRNA |
CTD |
PMID:23738040 |
|
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
increases expression multiple interactions |
ISO |
hydroquinone results in increased expression of MCL1 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]; [hydroquinone co-treated with WEHI-539] results in decreased expression of MCL1 protein; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein; PMAIP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]; SP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein] |
CTD |
PMID:35561756 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mctp1 |
multiple C2 and transmembrane domain containing 1 |
increases expression |
ISO |
hydroquinone results in increased expression of MCTP1 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
|
|
G |
Mctp2 |
multiple C2 and transmembrane domain containing 2 |
decreases expression |
ISO |
hydroquinone results in decreased expression of MCTP2 mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 1:125,769,932...126,002,886
Ensembl chr 1:125,771,233...126,002,928
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
ISO |
hydroquinone results in increased expression of MDM2 mRNA |
CTD |
PMID:29221148 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mettl21a |
methyltransferase 21A, HSPA lysine |
decreases expression |
ISO |
hydroquinone results in decreased expression of METTL21A mRNA |
CTD |
PMID:31256213 |
|
NCBI chr 9:65,934,253...65,999,964
Ensembl chr 9:65,978,051...65,987,550
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
hydroquinone results in increased expression of MGST1 mRNA |
CTD |
PMID:15452088 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mid1 |
midline 1 |
decreases expression |
ISO |